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Abstract 
Sarcopenia, a major concern in the older adult population, is defined as age-related 
loss of muscle mass and strength. Quadriceps muscle layer thickness (QMLT) 
measured using ultrasonography (US) is a newly-validated tool to measure muscle 
mass, which can be used to identify sarcopenic individuals. Our objective was to 
determine the association of factors such as handgrip strength (HGS), protein intake, 
nutritional status (via Subjective Global Assessment-SGA) and fat mass (FM) 
percentage with QMLT size (measured by US) in community-dwelling and 
institutionalized older adults. Additionally, we aimed to understand how perceived 
food intake of protein-rich foods could have an impact actual food intake. Sixty-three 
older adults ≥65 years (23 community-dwelling and 40 institutionalized older adults) 
took part in a cross-sectional study measuring differences in QMLT size, HGS, 
protein intake, SGA scores, and FM percentage between groups. Additionally, focus 
groups and individual interviews provided qualitative perspectives on protein intake. 
QMLT size was not significant between groups (p=0.358); however, HGS was 
significantly higher in community-dwelling older adults (p<0.001). When controlling 
for all variables, HGS showed a moderate positive correlation with QMLT size 
(r=0.432, p<0.0001) while protein intake was moderately negatively correlated 
(r=-0.361, p=0.004). HGS was the best predictor of QMLT size (b=0.391, 
r(63)=0.432, p=0.014) and QMLT measurements were highly reproducible 
(p<0.0001). Qualitative results found common themes such as regimented/routine 
eating patterns, lack of knowledge of protein-rich foods and physiological changes 
with age that could impact protein intake. Thus, HGS, nutritional status, and protein 
intake can have an impact on QMLT size, and US is a reliable tool to identify muscle 
size in older adults.
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Chapter 1 
1  Introduction  
Sarcopenia, defined as age-related loss of muscle mass, strength, and/or performance, is a 
major concern in the aging community. There is currently a lack of sufficient evidence on 
guidelines for prevention and treatment of sarcopenia (1, 2). Although sarcopenia can 
occur naturally due to age (3), lack of activity, disease and poor nutrition have all been 
linked to increased mortality (4). It is estimated that 1 in 20 community-dwelling and 1 in 
3 long-term care older adults (65 years and older) are identified as sarcopenic (5). 
Researchers continue to recognize different methods of measuring sarcopenia, however, 
there are inconsistencies in the development of cut-off points to define sarcopenia. 
Current validated tools used to measure muscle mass include Computed Tomography 
(CT), Dual Energy X-Ray Absorptiometry (DXA), Magnetic Resonance Imaging (MRI) 
and Bioelectrical Impedance Analysis (BIA), while handgrip strength (HGS) is the 
primary measurement method used to identify muscle strength (1). Emerging research has 
recently validated a novel approach to measure muscle mass using ultrasonography (US) 
on the quadriceps femoris muscle group (6). US used to identify quadriceps muscle layer 
thickness (QMLT) has been shown to be both a valid and reliable form of measuring 
muscle mass; however, it has only been used in certain population groups such as healthy 
young individuals and critically-ill hospital patients (6, 7). Considering the high 
prevalence of sarcopenia in institutionalized and community-dwelling older adults, 
research on QMLT is still warranted. Additionally, there have been no studies comparing 
results of muscle size using US between institutionalized and community-dwelling older 
adults. Measuring the quadriceps muscle using US in these populations may provide more 
information on the association of QMLT size with sarcopenia severity. This information 
may also provide insight regarding older adults’ living environment and its potential 
effect on muscle mass. 
1 
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Nutrition also plays a major role in the development and progression of sarcopenia. 
Malnutrition has been highly associated with decreased muscle mass and strength (8, 9). 
Older adults are at higher risk of not meeting their nutrient requirements due to 
physiological changes with age such as decreased appetite, altered smell, chewing and 
swallowing difficulties, gastrointestinal issues, and mental impairments (10, 11). These 
conditions can ultimately result in anorexia of aging, which can further accelerate loss of 
muscle mass and strength (11). On the other hand, higher fat mass and sarcopenic obesity 
can lead to complications such as increased inflammation and insulin resistance, which 
have also been associated with a decrease in lean muscle mass (LMM) (12). Protein 
consumption also plays a major role in muscle synthesis and preservation of muscle mass 
(13). Current recommended protein guidelines suggest consuming 0.8g/kg/d of protein; 
however, studies have suggested that this may not be adequate for adults over the age of 
55 (14). Tieland and colleagues have suggested that older adults in long-term care homes 
consume significantly less protein than community-dwelling older adults (15); however, 
there have not been any studies comparing the effect of protein intake on muscle 
size between institutionalized and community-dwelling older adults. Furthermore, 
minimal qualitative research has been conducted on older adults’ perceptions of protein-
rich foods, which may provide reasons why they may not be meeting their protein 
needs. Research in this area so far has suggested that there may be multiple barriers 
to protein consumption such as lack of access to shops, cost, safety, freshness/liking of 
food, and lack of knowledge of protein-rich foods (16, 17). Understanding why older 
adults may not be meeting their nutrition needs can assist researchers and clinicians 
to develop ways to help increase their consumption to help mitigate or prevent 
complications associated with sarcopenia.
Overall, there are currently no studies comparing QMLT using US of community-
dwelling to institutionalized older adults. There are also no studies that identify the 
association of other risk factors related to sarcopenia such as muscle strength, protein 
3 
intake, nutritional status and FM percentage and their effect on muscle mass. Additionally, 
qualitative research is important in understanding the reasons for inadequate protein intake 
in older adults.  
1.1  Rationale and Purpose of the Study  
The purpose of this study was to determine whether there is an association between 
specific risk factors such as HGS, protein intake, nutritional status, and FM 
percentage and size of QMLT in community-dwelling and institutionalized older 
adults. Furthermore, this study will also explore reasons behind lack of protein 
consumption in both of these groups to identify barriers to appropriate 
nutrient consumption.  
Using US technology, combined with other quantitative and qualitative measures, is a novel 
approach in identifying how certain factors can affect muscle size in older 
adults. This study will use US to measure muscle mass while combining 
other measurement methods of muscle strength, body composition of FM, nutrient 
intake and malnutrition assessment. Findings from this study may benefit the older 
adult community in providing a better understanding of how certain factors can 
influence their risk of sarcopenia. It will also benefit clinicians and researchers in 
creating a basis for developing new cut-off points of muscle mass using QMLT as 
a way to diagnose sarcopenia, as well as develop strategies to improve protein 
intake in the older adult population. 
1.2  Objectives 
1. To determine whether there is an association between specific risk factors for low
muscle mass and size of QMLT measured by US in community-dwelling and
institutionalized older adults.
2. To understand how perceived food intake of protein-rich foods could have an
impact actual food intake.
4 
1.3  Hypothesis 
1. QMLT size measured by US will be positively correlated with risk factors such as HGS, 
protein intake, and nutritional status, and negatively correlated with FM percentage in 
community-dwelling and institutionalized older adults.
2. Older adults in institutionalized settings will have lower QMLT 
size, nutritional status, protein intake, FM percentage, and HGS when compared to  
community-dwelling older adults.
5 
Chapter 2 
2  Literature Review 
The following chapter will discuss the background of sarcopenia, current 
methods of measuring muscle mass and strength, the role of nutrition and its relation 
to muscle mass and strength, sarcopenic obesity, and current barriers/new 
approaches in sarcopenia research. 
2.1  What is Sarcopenia? 
Sarcopenia—defined as age-related muscle loss resulting in decreased function and 
physical performance—was discovered in 1989 by Irwin Rosenberg (2). 
Sarcopenia is a common clinical complication for individuals over the age of 50 
and has been shown to cause poor physical outcomes resulting in decreased 
quality of life and increased mortality in the older adult population (1). 
According to The European Working Group on Sarcopenia in Older People 
(EWGSOP), two categories have been identified: primary and secondary 
sarcopenia. 
Primary sarcopenia, also known as age-related sarcopenia, results from 
natural aging processes (1). These natural aging processes include a reduction 
in sex hormones in both males and females (4, 18) and inflammation due to 
increased cytokine levels with age (19, 20). Additionally, other age-related factors that 
can lead to depleted muscle mass include skeletal muscle cell death associated with 
an increase in apoptosis inducing factors (21) as well as mitochondrial 
dysfunction and depletion of muscle stem cells due to muscle disuse and age-
related oxidative stress (22, 23).  
Secondary sarcopenia results from natural aging in addition to one or more factors; 
hence, it is also known as activity-, disease-, and nutrition-related sarcopenia (1). 
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Based on the EWGSOP, some of the factors involved in secondary sarcopenia are 
inactivity (long-term bed rest and sedentary lifestyle), diseases (organ failure, 
inflammation, anorexia, and cancer), poor nutrition (reduced energy/ protein intake), 
nutrient malabsorption, medications, and gastrointestinal dysfunction. Alongside these 
categories, sarcopenia can be further divided into three stages based on level of severity: 
presarcopenia, sarcopenia, and severe sarcopenia.
Presarcopenia identifies individuals with low muscle mass having no negative impact on 
strength and performance. Sarcopenia defines individuals with low muscle mass and 
either low muscle strength or performance. Severe sarcopenia combines all three aspects 
of low muscle mass, low strength, and decreased performance and can be seen in a wide 
range of older adults (Fig. 1) (1).
Finally, sarcopenia can be either chronic or acute. Chronic sarcopenia can be seen in 
individuals residing in community/long-term care settings, whereas acute state sarcopenia 
can be seen in hospital/bed-ridden patients (5).
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2.2  Risk Factors for Sarcopenia  
Many risk factors have been identified that can contribute to the development and 
progression of sarcopenia. These factors include hormonal changes (4, 18, 24), 
chronic disease, and/or inflammation (19, 20). For example, hormonal 
pathways that include insulin-like growth factor-1, growth hormone, estrogen and 
testosterone have been linked to decreasing muscle mass (24). A cross-sectional 
longitudinal study examining 1445 community-dwelling men found that lower levels 
of free testosterone were associated with increased mobility limitation and 
lower physical performance (18). Iannuzzi-Sucich and colleagues examined 
195 women ages 64–93 years and found that the prevalence of sarcopenia 
was significantly correlated with low levels of serum progesterone and estradiol 
(25). Therefore, diminished levels of male and female sex hormones can 
play a role in the natural progression of sarcopenia.  
As previously mentioned, mitochondrial dysfunction and chronic inflammation can 
also influence pathways in muscle loss from aging. In a cross sectional study comparing 
10 young (22 ± 2 years of age) and 10 old (77 ± 5 years of age) individuals, muscle 
biopsies from the vastus lateralis were taken and mitochondrial activity and 
inflammatory markers were examined (22). This study found that older 
individuals had increased levels of interleukin-6 and C-reactive protein 
(inflammatory markers) as well as mitochondrial changes from reduced 
cyclooxygenase, citrate synthase, and superoxide dismutase activity, all of 
which aid in reactive oxygen species elimination (22). The authors concluded 
that these inflammatory markers and mitochondrial changes in older adults render 
muscle cells prone to reactive oxygen species-mediated cell death resulting in 
the depletion of muscle mass (22).  
Chronic organ disease and the diagnosis of diabetes are other examples of 
conditions also shown to accelerate muscle loss and strength (24). For example, Park and 
colleagues investigated the impact of type 2 diabetes on skeletal muscle loss and 
body composition. Body composition was measured using DXA annually for 6 years.
9 
The study examined 2675 healthy community-dwelling older adults between the 
ages of 70–79. Results of the study found that older adults who were identified as 
having diabetes had significant loss of total body mass (particularly appendicular 
lean mass) when compared to individuals without diabetes (p<0.01). Interestingly, 
men in both groups seemed to have significant decline in muscle mass regardless of 
diabetes diagnosis when compared to women (p<0.04) and skeletal muscle 
declined two times faster in older women with diabetes as opposed to non-diabetic 
women (p<0.01) (26).  
Alongside biological processes, lifestyle factors such as food intake (particularly 
protein and energy) and sedentary lifestyle/prolonged bed rest have also been 
associated with increased muscle loss and decreased function (27). Although studies 
have also looked at associations between muscle loss and factors such as cognitive 
impairment, smoking, and alcohol consumption, two systematic reviews/meta-
analyses have concluded that sarcopenia was not greatly influenced by 
these factors (28, 29). Despite advancements in research on risk factors associated 
with sarcopenia, it remains prevalent in the older adult population (5). 
2.3  Prevalence of Sarcopenia  
Cruz-Jentoft and colleagues reviewed 18 studies that identified individuals (59–
85 years of age) with sarcopenia based on the EWGSOP criteria for 
defining sarcopenia (decreased muscle mass and strength or physical 
performance) in three major categories: community, long-term care, and acute 
care hospital settings (5). The prevalence of sarcopenia in both males and 
females ranged from 1–33% across all populations with higher prevalence 
among older and/or acutely-ill individuals (5). Among each category, 14–33% of 
individuals in long-term care settings, 1–29% in the community, and 10% in 
acute hospital settings were considered sarcopenic.
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The study concluded, according to the EWGSOP guidelines, that 1 in 20 community-
dwelling, and 1 in 3 long-term care/acutely-ill older adults are identified as having 
sarcopenia (5). Therefore, when sarcopenia was diagnosed using EWGSOP guidelines, it 
was associated with poor outcomes amongst older adults. This research provided insight 
on the potential prevalence of sarcopenia in the older adult population; however, more 
research is needed on better ways to detect sarcopenia using more modern and validated 
diagnostic tools. 
2.4  Outcomes of Sarcopenia  
Skeletal muscle weakness due to sarcopenia has been associated with decreased 
functionality and increased mortality in the older adult population and is an independent 
risk factor for osteoporosis (30), falls (31), length of stay in hospital settings (32) and 
mortality (33). In a systematic literature review and meta-analyses, Chang and colleagues 
(33) aimed to identify the association of sarcopenia with mortality. Of 309 studies taken
from multiple databases, 10 studies were identified with low heterogeneity and an
average follow up of 4.17 years. One thousand and ten deaths were identified among
3797 sarcopenic individuals diagnosed using guidelines adopted from EWGSOP for
identifying sarcopenia. These individuals had higher mortality rates when compared to
those with no sarcopenia (summary HR = 1.87, 95% CI = 1.61–2.18) (33). Consequently,
sarcopenic individuals are at a high risk of mortality and proper assessment tools may
help with early detection and prevention of poor outcomes.
2.5  Diagnosis of Sarcopenia  
Currently, there is no consensus on the best method to diagnose sarcopenia in the older 
adult population. EWGSOP provides guidelines for measurable cut-off points based
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on muscle mass and strength to help in the diagnosis of sarcopenia (1). These guidelines 
are based on Body Impedance Analysis (BIA), and dual energy X-ray absorptiometry 
(DXA) to measure muscle mass, hand-grip strength (HGS) to measure muscle 
strength and short physical performance battery (SPPB), usual gait speed, and 
“get up and go” tests to diagnose sarcopenia based on clinical practice (1). However, 
other measurements of measurements such as Computed Tomography (CT) and 
Magnetic Resonance Imaging (MRI) to measure muscle mass (34) and knee 
flexion/extension and peak expiratory flow to measure muscle strength (35) have 
also been used in the diagnosis of sarcopenia. 
2.6  Measuring Sarcopenia  
Sarcopenia can be currently identified using a variety of tools to measure muscle mass, 
strength, and physical performance based on the EWGSOP guidelines (1). 
2.6.1 Muscle Mass 
The EWGSOP has summarized a list of appropriate clinical tools to measure muscle 
mass, which primarily include MRI, CT, DXA, and BIA (1). 
2.6.1.1 Magnetic Resonance Imaging (MRI) 
MRI technology uses a magnetic field that directs the alignment of hydrogen 
nuclei, generating radio frequency signals (35). MRI can differentiate tissues and 
organs based on their magnetic resonance properties. These variations in 
frequency can also provide information on adipose tissue and fat-free mass (35). 
Benefits of using MRI include high accuracy and ability to measure muscle mass 
quantitatively and qualitatively without radiation exposure. MRI, however, can be 
costly, difficult to access, and require appropriate space and trained operators. As 
a result, this tool is mainly used in small-scale studies comprising of smaller sample 
sizes (24). Generally, MRI shows promising results in measuring muscle mass; however, 
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because of its disadvantages, other methods may be more appropriate for larger-scale 
studies. 
2.6.1.2 Computed Technology (CT) 
CT scans have demonstrated accuracy with their ability to “erase” other layers of soft 
tissue and evaluate muscle density to measure muscle attenuation, providing information 
on muscle strength with relation to health outcomes (24). CT scans take a shorter time to 
conduct over MRI; however, similar to MRI, high costs and limited availability mean that 
only small scale research studies have been conducted using CT (24).  
While CT scans and MRI have been shown to be very accurate and can precisely separate 
fat mass from other tissues, the disadvantages these imaging techniques impose is 
prompting researchers to identify alternative methods to measure muscle mass for large-
scale research (24). 
2.6.1.3 Dual-energy X-ray Absorptiometry (DXA) 
DXA uses X-rays to identify composition and thickness of material and has been the most 
popular method of measuring body composition. This is due to its relatively low cost, 
ease of use, and capacity to isolate appendicular skeletal muscle in the upper and lower 
extremities, which has been used to study sarcopenia (24). DXA was standardized in a 
large multi-component clinical trial, the largest study ever conducted on physical frailty 
and sarcopenia that included 1519 participants from 10 European countries (36). DXA 
has also been interpreted in the EWGSOP definition of sarcopenia as two standard 
deviations below the mean muscle mass of young healthy adults or a skeletal muscle 
index of 7.26kg/m2 for males and 5.5kg/m2 for females (1). Disadvantages of using DXA 
include lack of portability, lack of availability in primary care settings, and the 
inability to dissociate muscle mass from fat and fluid.
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Therefore, this can result in overestimation of muscle mass in edematous and obese 
individuals and lead to less accurate results (24, 37).  
2.6.1.4 Bioelectric Impedance Analysis (BIA) 
BIA is another method used to identify fat-free muscle mass (FFM) along with total body 
water content and FM percentage. An electrical current is passed through the body 
measuring impedance of body fluids with the notion that body water provides less 
impedance than adipose tissue (24). Janssen and colleagues (38) developed the 
following equation  to estimate muscle mass using BIA:  
Skeletal muscle mass (kg)=[(height (cm)2⁄ BIA resistance (ohms) × 0.401) + (gender × 
3.825) + (age (years) × − 0.071)] + 5.102     men=1 women=0 
The criteria used to create cut-off points for muscle mass in the EWGSOP for BIA is the 
Skeletal Muscle Index (SMI), which is measured by dividing skeletal muscle mass (kg) 
by height (m) squared (1). Low muscle mass is defined as an SMI lower than 8.87 
and 6.42 kg/m2 in men and women, respectively (38, 39). Advantages of using BIA 
include its ease of use, safety, portability, cost-effectiveness, and reproducibility in 
both ambulatory and bed-ridden individuals, as well its validation for individuals of 
different ages, sexes and ethnicities (24). Disadvantages include the potential variability 
in measurements that may arise due to hydration status, body position, food/beverage 
consumption, recent physical activity, body temperature, and measurement surface 
conduction. Overall, BIA can be a useful tool for measuring body composition to 
determine individuals at risk of sarcopenia. 
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2.6.1.5 Ultrasonography (US) to measure Quadriceps Muscle Layer Thickness (QMLT)  
Although not one of the methods verified by the EWGSOP, Ultrasonography (US) is 
a new method of quantifying muscle mass using tissue thickness. This technology 
uses an ultrasound beam to penetrate the tissue, which gets partially reflected 
back to the transducer and detected as an echo. The echo then gets converted to 
electrical signals to form a two-dimensional image (6). 
Measuring QMLT using US is a novel approach in identifying sarcopenia in older adults. 
QMLT consists of four major muscle groups: vastus lateralis, vastus medium, rectus 
femoris, and vastus intermedius (40). US technology has only recently has been validated 
to measure muscle mass of QMLT (6). Tillquist and colleagues (6) measured 
QMLT of healthy volunteers using US and found high test-retest reliability along 
with excellent inter- and intra-rater reliability. Intra-rater reliability was measured by the 
consistency of 48 pairs of measurements within the same subject, while inter-rater 
reliability was measured by comparing consistency amongst 78 pairs of measurements. 
Calculated inter-class correlation (ICC) scores for inter/intra-rater reliability established 
excellent results (ICC=0.98 intra-rater reliability, ICC=0.95 inter-rater reliability). This 
study concluded that individuals with no prior US experience demonstrated 
promising results when measuring QMLT on healthy individuals, and that US can be 
used to measure lean body mass (6). 
2.6.1.5.1 Validity and reliability of US technology 
Nijholt and colleagues (41) investigated the reliability and validity of US in comparison 
to DXA, CT and MRI to quantify muscle mass in older adults reviewed ICC scores 
among 17 studies in multiple databases (41). Scores were found to be the highest among 
quadriceps muscles such as the vastus lateralis (ICC=0.852–0.999) and rectus femoris 
(ICC=0.72–0.997) along with upper arm anterior (ICC=0.81–0.99) and trunk 
measurements (ICC=0.73–1.00) (41). All studies included in this review demonstrated 
excellent validity with ICC scores ranging from 0.92 to 0.999. 
15 
Findings from this review suggested that US technology is both a valid and reliable 
approach when used on large muscle groups in comparison to smaller muscle groups.
Overall, use of US technology to predict lean muscle mass (LMM) is a practical approach 
in identifying sarcopenia in older adults; however, more research is needed to validate 
approaches used for different population groups and older adults varying in function and 
health. 
2.6.1.5.2 Limitations of using US to measure muscle mass 
Along with being reproducible, advantages of using US technology include portability, 
safety, non-invasiveness, and radiation-free (42). US provides information on muscle 
thickness and muscle structure; however, error can arise due to similarity of impedance 
between adipose and muscle tissue (42). This can be a major disadvantage leading to 
potential misinterpretation of results. Another disadvantage is that error may also occur 
from the level of compression on the skin by the transducer (43). Minimal compression 
US techniques have been used in many studies on both healthy and unhealthy young and 
old individuals to minimize outcome error (40, 44-47). For example, Thomaes and 
colleagues (45) measured reliability and validity of US to measure the rectus femoris 
muscle in 45 older adults with coronary artery disease (45). This study used a minimal 
compression method to validate US by comparing it to CT, another gold-standard 
measurement method. Results concluded high test-retest reliability (ICC=0.97) and 
similar results of muscle mass when compared to CT (0.01 ± 0.12 cm; p=0.66). This 
study suggested that measurements of muscle size using minimal compression provide 
comparable results to muscle size measured using CT (45).  
Maximal compression, another method of measuring muscle mass with the US 
transducer, has also been justified in some studies. The benefits of using maximal 
compression techniques on edematous individuals may result in improved accuracy 
amongst those who are critically-ill (48). For example, Paris and colleagues (49) used US 
to measure QMLT thickness in critically-ill patients in the ICU ≥18 years of age. 
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These authors justified the use of maximal pressure in a critically-ill patient population 
due to the prevalence of edema (49). QMLT measured using US found a moderate 
correlation when compared to precise measurements of the abdominal muscle using CT 
(r=0.45, p<0.001). The study found that the largest group (young men) likely influenced 
these correlations as non-significant correlations were identified in the remaining groups 
(young women and older adults) (49). Therefore, this study concluded that techniques 
used for QMLT measurement may not accurately identify all patients with low muscle 
mass.  
Additionally, a more recent study conducted by Earthman and colleagues (50) evaluated 
methods of bedside US techniques to develop clinical guidelines for measuring skeletal 
muscle mass. Minimal compression allowed better identification of the thigh muscle, 
however, it was more difficult to identify differences in adipose and lean muscle tissue 
(7). The study also discussed the potential error of maximal compression due to the 
ranging degree of compressibility and low reproducibility amongst researchers, as well as 
the variability of individuals with the presence of edema or excess adipose tissue. 
Therefore, recommendations from this study were to use maximal compression to 
visualize the femur and gradually reduce the pressure until the outer margins of the femur 
are no longer visible before taking the measurement (50). This method would allow 
researchers to combine techniques to accurately visualize the muscle being measured and 
minimize potential error (50).  
In summary, research validating the appropriate method of compression to use is still 
warranted. Regardless of the method used, it is practical to use either technique as long as 
there is consistency of the measurement, thus supporting better interpretation of the 
results (42).
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2.6.2 Muscle strength 
Muscle strength is another important factor in the identification of sarcopenia. 
According to the EWGSOP guidelines, handgrip strength (HGS) is categorized as the 
primary measurement in clinical practice (1).  
2.6.2.1 Handgrip Strength (HGS) 
HGS has often been used to categorize muscle strength in individuals of all demographics 
(51). A well-calibrated dynamometer is typically used to measure grip strength and is a 
surrogate marker of muscle strength of the lower arms or legs (52). HGS ranges provide 
information on clinical outcomes associated with mobility in comparison to muscle mass 
(1). EWGSOP guidelines conclude that a HGS of <20kg for women and <30kg for men 
indicates the diagnosis of sarcopenia (1). Advantages of using HGS include cost-
effectiveness, availability, ease of use and high reliability (52). Bohannon and colleagues 
measured test and re-test reliability of HGS in 21 healthy older adults (ages 65–85) over a 
12-week trial period. Results displayed high ICC scores (0.954 left hand, and 0.912 right
hand, respectively), which were consistent with high reliability (51). One major
disadvantage, however, included the motivation or cognition of the individual tested,
which hindered the validity of this measurement (1).
2.6.2.2 Handgrip Strength in relation to mortality 
Some studies have suggested that muscle strength defined by HGS can predict old-age 
disability and mortality. A 25-year prospective cohort study by Rantanen and 
colleagues looked at whether midlife HGS could predict disability at an old age (52). 
The researchers measured maximal HGS (defined as the highest recorded HGS) in 
6,089 healthy Japanese men ages 45–68 living in Hawai from 1965–1970. A 
disability assessment was conducted on these individuals 25 years later
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(taking into account survival rate), including an evaluation of self-reported walking 
speed, ability to rise from a seated position as well as other mobility and self-care 
difficulties (52). Results indicated functional decline and mobility decreased over the 
years for those who initially were in the lowest cut-off point category for HGS (37kg), 
whereas individuals with the highest cut-off point for HGS (42kg) at midlife remained 
the strongest at old age (OR at 95% CI=2.87; 1.76–4.6 and 1.79; 1.14–2.81, respectively) 
(52). Similarly, another study done by the same group examined HGS of women and 
factors contributing to mortality such as inflammation, nutritional deficiency, physical 
inactivity, smoking, and depression (53). They evaluated 919 women ages 65–101 who 
were moderate-severely disabled (defined by an examination of self-reported difficulty of 
physical function) over 5 years. HGS was measured at baseline and after the study period. 
Those with the lowest HGS had a strong association with cardiovascular disease 
mortality (3.21; 95% confidence interval CI=2.00–5.14), respiratory mortality (2.38; 95% 
CI=1.09–5.20) and other mortality (2.59; 95% CI=1.59–4.20) when compared to those in 
the highest tertile of HGS. Factors contributing to mortality such as inflammation, 
nutritional status, physical activity, smoking, and depression did not explain the 
association, suggesting that HGS is a powerful predictor of all-causes of mortality (53). 
Overall, measuring HGS can be an easy and inexpensive method of identifying risk of 
disability associated with sarcopenia and can provide valuable information on muscle 
strength in association with sarcopenia in the geriatric population.
2.6.3 Muscle mass and strength: Validity and reliability of tools used to measure 
sarcopenia 
The validity and reliability of all of the aforementioned measurement methods were 
evaluated in a 2013 systematic review that assessed tools to measure muscle mass, 
strength, and physical performance amongst community-dwelling older adults (54). A 
total of 62 studies were reviewed in which validity and reliability of 10 different 
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tools were reported. Of these tools, MRI and CT were considered gold standard methods 
of measuring muscle mass. DXA was highly correlated with these models of 
measurement and BIA demonstrated high validity with significant differences in 
measurement of fat free mass (FFM) when compared to DXA. Good reliability and 
validity was found when comparing US to MRI. For muscle strength measurements, the 
HGS tool yielded inconsistencies largely due to various methods of dynamometer 
operation making it difficult to standardize a protocol for this method. While isokinetic 
measurements of the lower body are more consistent, HGS is a still good alternative due 
to its practicality (54). Overall, studies in reliability are still lacking when it comes to 
measuring muscle mass and strength and further research is still warranted.
2.7  Nutrient Intake and Sarcopenia: Protein  
2.7.1 Protein and age 
Protein intake has been highly correlated with prevention of sarcopenia, particularly 
when combined with resistance exercises, and plays a critical role in muscle synthesis 
and preservation of muscle mass (13). Aging has been associated with a 1–2% 
progressive decline in resting metabolic rate (RMR) each decade after 20 years of age 
(55). Skeletal muscle, which accounts for 80% of cell mass in young adults, has been 
shown to decrease to 40% of cell mass by the age of 75 (9). Decreasing mitochondrial 
protein synthesis and enzyme levels with age may affect oxidative phosphorylation in 
muscle mitochondria, which can disrupt protein synthesis and lead to age-related muscle 
loss. This warrants research into redefining the guidelines for protein requirements in 
older adults (9).
2.7.2 Current protein guidelines 
The current recommendation for protein intake amongst individuals’ ages ≥18 years is 
0.8g/kg/d. A recent review of protein requirements for older adults suggested that 
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recommended dietary allowances (RDA) for protein fail to provide adequate 
nutrition for older adults with respect to function (56). These authors suggested that 
the current recommendation does not take into account age-related muscle loss 
and decreased protein synthesis that comes with aging (56). A longitudinal study 
conducted on 10 healthy males and females ages 55–77 years looked at the effect 
of the current RDA protein guidelines and body composition after 14 weeks on a 
controlled protein diet of 0.8g/kg/d (57). While whole body composition (percent 
body fat, FFM, and protein plus mineral mass) did not change, mid-thigh muscle 
area had decreased at the 14-week period when compared to week 2 (p=0.019). 
Mean urinary nitrogen excretion also decreased within the same time period, 
suggesting an association with reduced metabolic activity. The study concluded that 
a reduction in skeletal muscle is possible after consuming a diet containing only 
0.8g/kg/d of protein; therefore, the current protein guidelines of 0.8g/kg/d may 
decrease muscle mass and accelerate sarcopenia in older adults (57). 
2.7.3 New proposed guidelines for protein 
A position paper in 2013 proposed specific protein intake guidelines of 1.0–1.2g/kg/
d as a general recommendation for individuals over the age of 65, 1.2g/kg/d for 
resistance and endurance training, and 1.2–1.5g/kg/d for acute and chronic disease 
(14). An overall recommendation of 25–30g per meal is suggested for everyone >65 
years of age (14). There is also evidence to suggest that consuming greater than 30g of 
protein in a meal does not result in increased protein synthesis in both younger 
and older individuals (58). Therefore, based on current evidence, 
recommendations for protein intake in individuals over the age of 65 in general 
is 1.0–1.5g/kg/d of protein; however, these guidelines have yet to be implemented 
as a standard for protein intake in older adults. New research has also suggested 
that older males may not require increased protein above the current RDA of 0.8g/
kg/d (59). In a randomized control trial, Bhasin and colleagues (59) measured 
parameters of lean body mass, muscle strength and other physical functional 
parameters in 92 functionally-limited older men (65 years and over) (59). 
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Participants were randomized over a 6-month trial period to either receiving the current 
RDA (0.8g/kg/d) or 1.3g/kg/d of protein with placebo with or without testosterone 
enanthate through prepared meals and supplements. Interestingly, no changes in lean 
body mass nor all other physical parameters were observed (p=0.24–0.89); however, in 
the higher protein group, FM significantly decreased (difference, -1.12 kg; 95% CI, -2.04 
to -0.21; p=0.02) (59). This study suggested that additional protein supplementation 
beyond the current RDA for protein in older men may not be necessary in preserving 
muscle mass and function, which may be an important consideration for future research. 
Research looking at the female population in this context, however, is still warranted.  
Overall, many studies have determined increased protein needs for the older adult 
population; however, new research has suggested that sex differences may be an 
important consideration when determining protein requirements in this population.
2.7.4 Types of protein 
There is evidence to suggest that type of protein may play a role in muscle 
synthesis. Symons and colleagues (58) sought to identify changes in protein 
synthesis after the ingestion of high-quality protein (lean beef). These authors 
found that post-prandial protein synthesis after ingestion of 30g of protein in lean 
beef increased the muscle fractional synthesis rate by 50% (p=0.008) in both young (35 
± 3 years) and old (68 ± 2 years) individuals. However, consuming double that 
amount did not further enhance protein synthesis in either group (58). Older adults, 
however, demonstrate more positive whole-body protein balance after ingestion of 
rapidly-absorbed protein such as whey, compared to younger individuals, who benefit 
more from slow-absorbed protein such as casein (60). In a randomized double-
blind controlled intervention study, Karelis and colleagues (61), 84 participants were 
randomized to either a whey or casein group and received 20g of either supplement.
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84 participants were randomized to either a whey or casein group and received 20g of 
either supplement. After completing a 135-day study period that combined resistance 
training, a significant increase was observed in absolute body mass (31%), normalized by 
body weight (30.9%) and lean body mass (30%) after consuming a cysteine-rich whey 
supplement when compared to the casein group (p<0.005). Overall, supplementing whey 
protein of 20g/d in combination with resistance training showed gain in muscle strength 
(61). Rapidly-digested protein, however, is also an important consideration when 
associated with aging and chewing/swallowing difficulties. In other research, minced 
beef compared to beef steak, was more rapidly digested, resulting in greater postprandial 
protein retention and amino acid availability (62). Therefore, type and digestibility of 
protein are important considerations when looking at the impact on muscle synthesis. 
Additionally, some amino acids such as leucine may have a greater impact on muscle 
synthesis.  
2.7.4.1 Leucine 
Leucine, a branched chain amino acid, has been shown to be the most potent amino acid 
involved in the synthesis of protein (63). This essential amino acid, found in both animal 
and plant sources of protein, works synergistically with resistance exercise to increase 
muscle mass (63). Interestingly, leucine has been shown to both stimulate protein 
synthesis and decrease muscle breakdown. It is involved in the regulation pathways for 
cellular processes such as an increase in global mRNA transcription, which increases 
protein synthesis and is a strong insulin secretagogue (13). One study (63) evaluated 
leucine supplementation (4g/meal, 3 meals/day) for 2 weeks on 8 healthy sedentary older 
adults already consuming the RDA for protein (0.8g/kg/d). Venous blood and biopsies of 
the vastus lateralis were obtained during the study period. Parameters measured included 
muscle synthesis, body composition, and nutrient signaling before and after the study 
period. Within 2 weeks of leucine supplementation, post-absorptive muscle 
synthesis increased significantly (p=0.004) while other parameters remained the same 
(63).
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Results from this study suggest that improved protein synthesis may be seen 
with leucine supplementation (63). A systematic review and meta-analysis 
examined the effects of leucine supplementation on muscle mass and strength (64). 
A total of 16 studies concluded that leucine supplementation (ranging from 2–7.8g/
d) increased body weight, lean body mass (LBM), and body mass index (BMI).
Leucine supplementation also showed to be the most effective in individuals
diagnosed with sarcopenia (64). However, a more recent meta-analysis reviewed
randomized control trials (RCTs) of dietary protein and amino acid
supplementation effects on muscle mass and strength (65). A total of 8 meta-
analyses and 6 randomized double-blind placebo-controlled trials were included in
the study. Both meta-analyses and RCTs showed no significant positive effects
on lean body mass (mean difference: 0.014 kg: 95% CI=-0.152; 0.18 and n=412:
p=0.78), leg-press strength (mean difference: 2.26 kg: 95% CI=-0.56; 5.08 and
n=121: p=0.50), leg extension strength (mean difference: 0.75 kg: 95% CI=-1.96,
3.47 and n=121: p=0.16) and HGS (mean difference: -0.002 kg: 95%
CI=-0.182; 0.179 and n=318: p=0.37). This analysis concluded that there is
no evidence to suggest supplementation with amino acids such as leucine has
benefits in older adults by increasing muscle mass and strength without
the combination of other nutritional interventions for a healthy diet and
exercise on healthy older adults (65). Consequently, research is still needed
to examine how protein and particularly leucine intake can prevent sarcopenia in
older adults.
2.7.5 Protein and Sarcopenia prevention 
As previously discussed, protein is important for muscle synthesis and can play a major 
role in sarcopenia prevention. It is essential to recognize inadequacies of protein intake 
and the effects of protein supplementation on muscle mass and strength in 
the prevention of sarcopenia. Tieland and colleagues (15) assessed the inadequacies 
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of protein intake amongst healthy and frail older adults in the community, as well as in 
institutionalized older adults (15). These authors reported institutionalized older adults 
having the lowest dietary intake of protein (56 ± 17 g/d for men and 55 ± 15 g/d for 
women, 0.8 ± 0.3 g/kg/d) and community-dwelling older adults having the highest protein 
intakes of 85.9 ± 23.9 g/d for men and women, 1.1 ± 0.3 g/kg/d (p<0.001). Frail older 
adults averaged 1.0 ± 0.3g/kg/d protein per day. Amongst all groups, breakfast showed 
the lowest protein intake (10 ± 10 g in the community, 8 ± 5 g in the frail older 
individuals, and 12 ± 6 g in the institutionalized older individuals). Thirty-five percent of 
institutionalized and 10% of community and frail older adults were consuming less than 
0.7g/kg/d of protein (15). Tieland and colleagues (15) concluded that institutionalized 
adults are at a great risk of not meeting protein requirements and are an important target 
for nutrition interventions.  
A randomized double-blind placebo-controlled diet also conducted by Tieland and 
colleagues (66) evaluated protein supplementation and physical performance on frail 
older adults. Frailty was defined using specific criteria that included unintentional weight 
loss, weakness, self-reported exhaustion, slow walking speed, and low physical activity. 
Sixty-five participants were randomly assigned to either protein supplementation (15g of 
protein at breakfast and lunch) or a placebo for a 24-week trial period. Muscle mass, 
strength and physical performance were assessed at baseline, halfway through the study, 
and at the end of the study. Although skeletal muscle mass did not change, significant 
improvements were seen in muscle strength amongst both groups (p<0.01) with leg 
extension increasing to a greater extent in the protein group (66). Physical performance 
improved significantly amongst the protein group in comparison to the placebo 
group (p=0.02). These authors concluded that protein supplementation in frail older 
adults can improve physical strength and performance (66).
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Another randomized control study looked at the preventative effect of protein 
supplementation on functional decline on 87 frail older adults with low socio-
economic status in the community (67). Participants were randomly assigned to the 
intervention group receiving a protein-rich drink to consume once a day 
(intervention), or the non-protein supplement group (control). Physical 
functioning, physical performance battery, usual gait speed, timed up and go test, 
HGS, and one-legged stance were measured. The major changes identified in this 
study were an increase in short performance battery (p=0.039) and an 
increase in physical functioning (p=0.052) in the intervention group when 
compared to the control group. The intervention group also showed 
improvements in the timed up and go test (p=0.038). Despite observing a 1% 
reduction in usual gait speed in the intervention group, the control group showed an 
11.3% reduction in the same test (p=0.039). Overall, protein supplementation in frail 
older adults with low socioeconomic status can reduce the progression of functional 
decline (67). 
Furthermore, another randomized, double-blind placebo-controlled trial  
evaluated the results of the combination of vitamin D and leucine-enriched 
whey protein supplementation and the prevention of sarcopenia in older adults 
(68). Three hundred and eighty older adults identified as sarcopenic 
(based on a low physical performance battery score and SMI) were randomly 
assigned to either an active or control group. The active group received 
supplementation of vitamin D and leucine-enriched whey supplement to consume 
twice daily for 13 weeks, whereas the control group just received an iso-caloric control 
product to consume for the same period. Measured outcomes tested before 
and after the trial period included HGS and short performance battery score, 
along with other secondary variables such as gait speed, chair-stand test, balance 
score, and appendicular muscle mass. Study results showed that the active group had 
an overall significant improvement in the chair-stand test (p=0.018) and increased 
appendicular muscle mass when compared to the control group (p=0.045). 
26 
This study concluded that nutritional supplementation of leucine-enriched whey 
protein combined with vitamin D can improve muscle mass and lower 
extremity function in older adults (68). In conclusion, these studies  
concluded that protein supplementation can reduce age-related muscle loss, 
enhance physical strength, and improve overall health outcomes in older adults.  
2.7.6 Qualitative research on perspectives of protein intake in older adults 
Qualitative approaches (focus groups, interviews, surveys, and questionnaires) to explore 
protein intake can be helpful in identifying barriers to consuming protein, which can 
allow for a better understanding as to why individuals may not be meeting their protein 
needs. A study by Best and colleagues (69) conducted focus groups with 28 
community-dwelling older adults to identify factors associated with consumption of 
specific high-protein foods including meat, fish, eggs, dairy products, nuts, and 
pulses. Thematic analysis resulted in product-based, environment-based, and 
cognitive-based barriers to protein consumption. Product-based barriers included taste, 
texture, and odour of foods, all of which can be affected by loss of natural teeth and 
the wearing of dentures. Freshness, quality, and safety of food were also factors identified 
as barriers to appropriate protein consumption. Environmental reasons included 
living situations, convenience, restricted mobility due to physical impairments, and 
access to shops. Living alone and cost of meat were also identified as barriers due 
to protein’s highly-perishable nature and cooking for one. Finally, cognitive-based 
barriers included access to health information, level of education, and food crises 
leading to a lack of understanding of the importance of protein-rich foods (69). Overall, 
these authors identified many different reasons why older adults may not be meeting 
their protein requirements.   
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Heuvel and colleagues (16) conducted focus groups and interviews with 39 independent 
living individuals between the ages of 56–84. Focus groups were divided by sex and 
employment status. Using thematic analysis (), many themes similar to the Best 
and Appleton (69) study were identified. These included hedonics (liking), properties of 
food (taste, texture), preparation style, convenience (time and effort to cook), physical/
health ability, nutrition and health knowledge, food safety, social environment, 
morality of animal welfare, emotions, and habit (upbringing) (16). Based on 
these results, a questionnaire was developed, which assessed UK community-dwelling 
older adults over the age of 65 (17). Appleton (17) evaluated usual consumption of 
meat, fish, eggs, and dairy products; perspectives on consumption of these foods; and 
demographic/lifestyle characteristics. When the 384 questionnaires were analyzed, higher 
intakes of meat, fish, eggs, and dairy were associated with higher liking (p=0.01–0.04). 
Meat was associated with greater perceptions of convenience and affordability 
(p=0.03–0.04), fish with importance of freshness and less effort to prepare/cook 
(p=0.03–0.05), and eggs as being convenient with decreased spoilage and waste. 
Factors such as likability, convenience, freshness of food, and cost/affordability hinder 
consumption of protein-rich foods (17). Overall, many common themes have emerged 
from these qualitative studies that indicate a need for creating strategies that focus on 
increasing liking/tastiness of protein-rich food, improving food preparation skills, 
reducing costs, increasing knowledge, and creating better access to protein-rich foods.
2.8  Nutrient Intake and Sarcopenia: Energy Intake 
Along with protein intake, energy and overall nutrients from food have a great impact on 
muscle mass. Individuals not meeting their appropriate requirements may lose more lean 
body mass, strength and overall physical performance (8).  
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2.8.1 Energy intake, anorexia and frailty 
Reduction in energy consumption is common in older adults and is usually due to 
decreased appetite and anorexia of aging (10, 11). Anorexia of aging is defined as 
weight loss due to decreased appetite, altered smell, physiological and hormonal 
changes, slowed gastric emptying, chewing/swallowing issues as well as mental 
impairments (11). These factors not only affect an individual’s desire for food, 
but ability to prepare and access food, resulting in a lack of appropriate 
nutrition that can ultimately lead to increased frailty and sarcopenia (10, 11). Energy 
intake (as resting energy expenditure) is currently estimated based on the 
Harris Benedict formula, which takes into account weight, height, age, sex and 
activity factor (70). Energy intake and its relation with frailty was identified in a 
study by Bartali and colleagues (71), which evaluated data from 802 
participants ages 65 or older of the inCHIANTI study. Frailty was identified 
using parameters of low muscle strength, walking speed, physical activity, and 
feelings of exhaustion. Results of the study revealed energy intake of 21kcal/
kg/d was associated with increased frailty in individuals >65 years old, with 
frailty being defined as individuals with an impeding risk of deterioration, high 
degree of disability and risk of death (OR: 1.24; 95% CI=1.02–1.5) (71). Later, 
a finding from the National Health and Nutrition Examination Survey 
(NHANES) in 2013 on 4731 individuals over the age of 60 confirmed that 
daily energy intake was the lowest amongst frail individuals (mean kJ ± SE: 6648 ± 
130) and highest amongst individuals who were not considered frail (7280 ± 84,
p<0.01) (72). Landi and colleagues (73) evaluated data from 364 study subjects
in the ilSIRENTE prospective cohort study. Measurements of physical
performance, muscle strength, and anorexia were conducted. The aim of this study
was to find correlations between physical performance, muscle strength, and anorexia.
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Results showed a significant association with low physical performance scores 
and anorexia (p=0.03), along with low HGS and anorexia (p=0.3) (73). 
Furthermore, participants identified as anorexic also showed an increased 
chance of developing disabilities after a 2-year follow-up (73). These studies 
overall conclude that, without the appropriate consumption of energy 
and nutrients, individuals are at higher risk of poor outcomes associated with muscle 
loss and reduced physical performance. 
2.9  Malnutrition in Older Adults 
Malnutrition has been a major concern in the older adult population and has been 
shown to be a result of complications associated with anorexia of aging, chronic 
and/or acute illness, and decreased food intake (74). Health-care professionals in 
acute and long-term care settings have used validated screening tools to assess the 
risk of malnutrition of individuals. These include the Malnutrition Universal 
Screening Tool (MUST), Nutritional Risk Screening 2002, Mini Nutritional 
Assessment® (MNA), Short Nutritional Assessment Questionnaire© (SNAQ),
Malnutrition Screening Tool (MNST), and the Subjective Global Assessment (SGA) 
(75). Studies using these validated malnutrition assessment and screening tools 
have repeatedly found an association between malnutrition and multiple 
co-morbidities. For example, one study found that amongst 413 geriatric 
clinic outpatients, poor nutritional status measured using MNA was associated with 
increased rates of depression as well as cognitive and functional decline (p<0.0001) (74). 
A 2013 systematic review and meta-analysis of 24 eligible cohort studies and 
intervention trials of individuals ages 65 and older suggested malnutrition was 
associated with overall poor physical quality of life (p<0.001) (76). Malnutrition has 
been shown to also be particularly evident in community-dwelling as well as 
institutionalized older adults. A prospective study of 579 home-living older adults 
used MNA to detect levels of malnutrition in association with factors such as 
HGS, depression, cognitive function, health-related quality of life, well being, 
and other demographic and biochemical examinations (77). 
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According to the MNA, the prevalence of risk for malnutrition was 14.5% 
(p=0.006) and the strongest risk factors for malnutrition were HGS and lower 
perceived health (p<0.001) (77). 
Research studies have also repeatedly shown the high risk of malnutrition in 
institutionalized older adults (78, 79). Older adults admitted to long-term care institutions 
in particular may have many illnesses and complications such as dementia, depression, 
loss of autonomy with daily activities, decreased ability to feed themselves, and chewing/
swallowing difficulties, along with the risk of drug-nutrient interactions from medications 
to treat co-morbidities (80, 81). A 2015 systematic review looked at the prevalence of 
malnutrition in Ontario long-term cares homes in relation to food intake and swallowing 
impairments (dysphagia) (82). The prevalence of dysphagia and malnutrition ranged from 
7–40% and 12–14%, respectively. The review concluded that increased nutrition needs of 
institutionalized older adults are essential (82). A more recent 2016 prospective study also 
looked at the prevalence of malnutrition risk and sarcopenia in nursing homes as well as 
the association with mortality (83). An MNA was used to determine nutritional status 
while sarcopenia was measured using EWGSOP guidelines. Results showed that 24.8% 
and 18.7% had malnutrition risk and malnutrition, respectively, and both were strongly 
associated with sarcopenia (p<0.0001) (83). A 12-month follow-up revealed a 16.2% 
mortality rate, which was correlated with malnutrition (p<0.001) and sarcopenia 
(p<0.012) (83). 
Therefore, validated screening tools used in research have been able to 
provide  evidence of the prevalence of malnutrition in older adults and the need for 
appropriate intervention in this population.  
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2.10  Increased Fat Mass in Sarcopenic Obesity 
Sarcopenic obesity is described as low muscle mass in obese older 
adults; however, like the general term “sarcopenia”, no clear definition 
has been identified (84). Age-related sarcopenic obesity occurs when a decline 
in LMM is replaced by fat mass or vice versa, with prevalence ranging from 4–94% 
(85, 86). Many complications have been associated with sarcopenic obesity such as 
an increase in inflammation, insulin resistance, leptin resistance, and low levels of 
testosterone, all of which have been associated with decline in muscle mass (12). 
Obese sarcopenic individuals have also been shown to have poor physical function 
and cardio-metabolic health as well as increased risk of falls, fractures, and overall 
mortality (12). For example, one study examined 3,366 community-
dwelling women and men >65 years of age who did not have cardiovascular disease 
(CVD) at baseline (87). Measurements of waist circumference and muscle strength were 
modestly associated with increased CVD risk in the sarcopenic-obese group (p=0.06) 
(87). Another study evaluated physical function and fat mass in 1308 sarcopenic, obese, 
and sarcopenic-obese community-dwelling healthy women over the age of 75 (88). 
Anthropometric measures along with lifestyle habits, health status and self-reported 
difficulties were documented. Results showed that sarcopenic women had no increased 
odds of difficulties associated with physical function. Obese women, however, had more 
difficulties with physical function (p<0.05) and sarcopenic obese women had the greatest 
significance in difficulties with physical function (p<0.05). Therefore, sarcopenia with 
the presence of obesity in community-dwelling women may pose an increased risk of 
physical difficulties (88). As previously discussed (section 2.7.5) in new research on 
older males, higher protein intake (1.3 g/kg/d) can also result in a decrease in FM over a 
6-month period (p=0.02), which may result in less incidence of sarcopenic obesity (59).
Weight loss through appropriate nutrition and physical activity combined with
adequate protein intake have shown positive outcome in this population; however, more
research is needed in providing an appropriate definition as well as specific clinical
interventions (12).
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2.11  Barriers to Assessing Sarcopenia 
Barriers in research can complicate the assessment and diagnosis of sarcopenia in older 
adults. One major barrier in assessing sarcopenia is the lack of homogeneity of 
studies that measure muscle mass and strength, thus leading to inability to establish 
appropriate and agreed-upon cut-off points. This can also cause inconsistent 
consensus on the definition of sarcopenia and sarcopenic obesity. Without a 
unanimous definition, prevention and treatment plans cannot be created appropriately. 
Studies have also not yet shown the effects of combining multiple measurements 
of muscle mass and strength to assess sarcopenia while linking other risk factors 
such as nutritional status and protein intake. Similarly, no research has 
combined a qualitative approach to protein intake with quantitative data on 
muscle mass and strength. The EWGSOP also provides a list of questions that 
have yet to be answered. These include questions pertaining to the role of 
nutrition and physical activity interventions, supplements, and medications in the 
prevention of sarcopenia (1).  
2.12  Summary 
Sarcopenia is defined as age-related muscle loss, decreased function, and 
physical performance (1). It is a common clinical complication for individuals over the 
age of 50 and has been shown to cause poor physical outcomes, reduced quality 
of life and increased mortality in the older adult population (1). Many tools have been 
validated to measure muscle mass and strength and have been included in the EWGSOP 
consensus on sarcopenia definition and diagnosis. The use of US to measure muscle 
mass, particularly the quadriceps region, has only recently been validated and is 
promising in both clinical and research-based settings (6). Protein and energy 
requirements have been re-evaluated for older adults due to the progressive loss of 
muscle function with age and occurrence of anorexia of aging. Qualitative research 
conducted on nutritional intake of protein has suggested there is a need to create 
strategies that focus on increasing liking/tastiness of protein-rich food, improving    
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food preparation skills, reducing costs, increasing knowledge, and creating better access 
to these foods to increase protein consumption in the older adult population.
Finally, the use of new research tools such as US in combination with qualitative 
and quantitative approaches may provide more information on prevention strategies 
and overall sarcopenia research.  
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Chapter 3 
3  Methods  
3.1  Ethical Approval 
The following study has been reviewed and approved by the Western University Health 
Science Research Ethics board (WHSREB) for the use of human participants (Appendix 
A).
3.2  Study Design 
This was a cross-sectional study evaluating the association of risk factors such as SGA 
scores, FM percentage, muscle strength, and protein intake and their relationship 
with QMLT size in institutionalized older adults in a long-term care home compared 
to community-dwelling older adults. Additionally, this study used a qualitative 
approach to identify barriers to protein intake. Community-dwelling participants 
were recruited from multiple locations in the community and institutionalized 
older adults were recruited from a long-term care facility in London, Ontario.  
There were a total of 5 quantitative independent variables in this study: HGS, protein 
intake, FM percentage, SGA scores, and group (institution versus community). Protein 
intake was obtained using food intake records; nutritional status was collected using a 
validated SGA tool, HGS was measured using a dynamometer; and FM percentage was 
measured using bioelectric impendence analysis (BIA). The dependent variable was 
QMLT size and was measured using US. Qualitative data were obtained using focus 
groups in the community and individual interviews in the institution.
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3.3  Volunteer Recruitment and Training 
Volunteer undergraduate nutrition students were recruited via email to assist with data 
collection. All volunteers were required to sign a confidentiality form and read over the 
requirements to assist in data collection (Appendix B). All volunteers were required to 
complete a police check and attend a training session for conducting and analyzing food 
intake records, assist with recording of measurements, and conduct phone interviews for 
the 24-hour recalls with community-dwelling participants. Volunteers were also 
required to complete a fire safety and resident abuse-training course provided by the 
long-term care home to have permission to access the residents at the institution.
3.4  Study Subjects 
Sample size: To obtain an appropriate sample size, a range of 10–15 participants was 
chosen for each of the independent variables to ensure a non-biased statistical 
representation (89). The aim was to meet the higher end of the range (15 participants/
variable) to ensure a large enough sample size for statistical analysis. Five independent 
variables (protein intake, HGS, FM percentage, SGA scores, and group) were evaluated; 
therefore, the aim was to obtain 75 participants (15 participants X 5 variables). A total of 
63 participants (Males: 5 community-dwelling, 12 institutionalized; and Females: 18 
community-dwelling, 28 institutionalized) completed the study.  
All 63 participants in the study met the following inclusion criteria: 
• Adults 65 years of age or older
• English-speaking
• Low-risk defined as: ambulatory (including use of an ambulatory device),
cognitively sound, able to provide consent and follow simple instructions
Exclusion criteria included: 
• Completely bed-ridden (inability to move or sit upright)
• Have a pacemaker (interference with BIA measurements)
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3.5  Participant Recruitment 
All individuals were recruited on a volunteer basis and measurements were 
conducted in a private setting.  
Institution: Approval was obtained from the Executive Director and 
Registered Dietitian (RD) at the long-term care home prior to proceeding with 
the research project. All individuals conducting research (3 researchers and 10 
volunteers) were required to receive resident abuse and fire safety training. Prior 
to data collection, the study was explained to all participants and a letter of 
information and consent were signed (Appendix Ci). Measurements were 
taken at convenient times without conflicting with meal times or activities. 
Overall, 40 participants completed the study from the institution.  
Community-dwelling: Community-dwelling participants were recruited at 3 
different community settings. Overall, 23 community-dwelling participants completed the 
study. 
Setting 1: Retirement residence (first location) (N=10): Posters were displayed at an 
arboretum with information regarding the study (Appendix D). Interested 
individuals received a letter of information and consent form (Appendix Cii). 
Following measurements, participants were then provided with a 3-day food record 
and stamped envelope to complete and mail back to the Principal Investigator 
(PI). Ten participants completed all data required for the study. 
Setting 2: Retirement residence (second location) (N=9): The research team 
presented the study project during an event and interested individuals were 
provided with a letter of information and consent form (Appendix Cii). Participants were 
then provided with a 3-day food record and stamped envelope to complete and mail back 
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to the PI. For participants who ate in the retirement home dining room, food intake 
quantities and recipes were provided by the chef at the residence (Appendix Ei). 
Nine participants completed all data required for the study.  
Setting 3: Apartment residence (N=4): Permission to recruit participants was 
obtained from the property manager. A poster was displayed and all participants 
interested received a letter of information and a consent form (Appendix Cii). 
Participants were then provided with a 3-day food record and stamped envelope to 
complete and mail back to the PI. Four participants completed all 
measurements required for the study. 
3.6  Data Collection: Quantitative 
Quantitative data on QMLT size, HGS, protein intake, FM percentage and other 
descriptive measurements were collected using the following research tools. 
3.6.1 Ultrasonography 
Ultrasonography was used to measure QMLT size in both population groups. A 
portable ultrasound machine (FUJIFILM SonoSite Mturbo) was used to take 
measurements. A medical directive was signed by two physicians for dietitians 
conducting the measurement at the long-term care home (Appendix F). Protocol 
guidelines for the use of ultrasound to measure QMLT were adopted from Tilquist and 
colleagues (6) and Wojda and colleagues (48) (Fig. 2; Appendix P). Participants 
would lie supine with knees extended. A midpoint between the patella and 
anterior superior iliac spine were located followed by the application of a 
water-soluble transmission gel. The transducer was pressed against the skin surface 
at 90° to identify the femur. Once an image was captured, the quadriceps 
muscle was measured using electronic calipers in centimeters. A total of 3 
measurements were taken on each leg and the average of each measurement was 
reported.
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Figure 2. A schematic summary of QMLT measurement. QMLT measurements were 
adopted from Tillquist et al., 2015 (6). For the purpose of our study, reading #1 was used to 
measure QMLT size of participants using US.
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3.6.2 Bioelectrical Impedance Analysis (BIA) 
BIA was used to measure body composition with specific interest in FM 
percentage. Protocol guidelines for the use of BIA were adopted from Earthman and 
colleagues (50). Briefly, the BIA device (BodyStat® 1500 Analyzer) was used to 
measure the impedance value of the body providing a quick and effective analysis 
of body composition at a fixed frequency of 50kHz (Appendix G). Height, weight and 
age were either taken from patient charts (at the long-term care institution) or 
requested from individuals in the community to input into the device. Research 
personnel placed 4 electrodes on the right side of the body (2 on one hand and 2 on one 
foot). Two main cables each with two alligator clips leading from the machine were 
connected to each tab of the electrodes. Once initiated by pressing a button on 
the device, a safe battery-generated signal passed through the body while 
measuring the impedance at a fixed frequency. Measurements were taken once 
and the FM percentage values were recorded in both study groups.  
3.6.3 Dynamometer 
HGS was measured in both population groups using a calibrated dynamometer 
(JAMAR). The dynamometer was calibrated previously by the factory and 
serviced twice during the study period to ensure accuracy. Measurements were 
conducted following the protocol adopted from the JAMAR manual (Appendix H) and 
the Southhampton Model (90, 91). Briefly, the participant would sit 
comfortably with shoulder adducted and neutrally rotated, elbow flexed at 90° and 
feet flat on the floor. Participants squeezed as hard as possible until the needle on 
the device stopped rising while research personnel held the bottom of the device during 
the process to ensure stability during the measurement. The peak-hold needle 
automatically recorded the highest force exerted. Measurements were read 
and recorded 3 times on each hand and the highest grip score out of all trials was 
reported (90, 91). 
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3.6.4 Food intake Records 
Food intake records were obtained from both the community and institution with a 
focus on protein intake.  
Institution: 
Food intake records from institutionalized older adults at the long-term care home were 
recorded over 3 days and included breakfast, lunch, dinner, and snacks via direct 
observation. Each food record included the participant code number, information on 
dietary needs/restrictions (if any), supplements, mealtime, food type, amount, and 
extra notes (Appendix I). To ensure accuracy, each volunteer observed no more than 
2 participants at one given time and recorded the amount consumed once the 
participant had indicated he/she was finished eating. Menus with portion sizes of each 
meal were provided to volunteers and amounts were recorded based on 
estimations of food consumed. A food intake instruction guide was created by 
research personnel and provided to volunteers to use at the institution (Appendix 
J). For snacks, volunteers visited participants throughout the day over a 3-day period 
to ensure all food consumed by the participants was recorded.  
Community: 
Option 1- Food intake from community-dwelling participants were recorded over 3 
days and included breakfast, lunch, dinner, and snacks. Additionally, a 24-hour 
recall was conducted and recorded during the initial visit (Appendix I). Participants were 
trained on how to record their food intake and a sample food intake record was 
provided. A 3-day food record including information on the date, meal, food 
description, amount, extra notes, and supplements was provided to the participant. 
Participants were asked to mail all information to the PI (Appendix I).
Option 2- another option for the participants was to have an experienced volunteer call to 
collect three 24-hour recalls in a week. Volunteers were provided with a phone script 
to use to collect over-the-phone food intake (Appendix K).
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Only one participant requested this approach. For individuals who consumed their 
meals at a retirement residence, food intake from their food records was analyzed 
using guidance from a menu and recipes for serving sizes provided from the location 
(Appendix Eii).  
For food intake record analysis, eight volunteers with previous experience in food intake 
analysis using the ESHA program were evaluated for their ability to accurately 
input food intake data into this software. Volunteers who were able to obtain the closest 
ESHA output values to the two primary research personnel involved in this study 
were chosen to assist in the food analysis portion of the study. Of these volunteers, 
four analyzed all food intake data using ESHA Food Processor® (Version 11.1). All 
ESHA nutrient intake outputs were summarized into an Excel document and 
transferred to SPSS (Version 25) for statistical analysis. 
3.6.5 Subjective Global Assessment (SGA) 
Nutritional status using SGA was also obtained from community-dwelling and 
institutionalized older adults. The SGA form, used from the Canadian Malnutrition 
Task Force, is a gold standard validated assessment tool used to identify 
malnutrition risk (75)(Appendix L). A dietitian research team member completed 
the SGA form using information from on-site medical records at the long-term care 
home as well as verbally communicating with the participant (in the community and 
institution) to ask questions relating to nutrition history. Participants were given a 
score of “A” (well nourished), “B” (mildly or moderately nourished with some 
progressive nutritional loss) or “C” (severely malnourished with evidence of 
wasting and progressive symptoms of reduced oral intake) depending on the 
information provided (75).
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3.6.6 Descriptive data 
Other measures that were taken from participants included height, weight, age, and level 
of ambulation. Information on height, weight, and age were all taken from patient charts 
at the institution or requested from the participants in the community. Individuals in the 
institution were assessed by a dietitian for level of ambulation. If level of ambulation was 
not apparent, the dietitian would ask the participant directly or discuss this with their 
caregiver/health care professional. Ambulation was divided into three categories: fully 
ambulatory, ambulatory with an assistive walking device (cane), and ambulatory using a 
wheelchair/walker. Current guidelines for HGS (1), protein intake (14), and FM 
(Appendix O) were summarized from updated research to identify the percentage of our 
participant population meeting guidelines of these variables. Data were directly recorded 
in the primary Excel document. All data collection forms for quantitative analysis can be 
found in Appendix M.
3.7  Data Collection: Qualitative  
Qualitative data for this study were obtained using focus groups and individual 
interviews. The aim was to gain a better understanding of participants, perceived ideas 
regarding obtaining adequate dietary protein. A total of 4 focus groups consisting of 3–5 
individuals in the community and 4 individual interviews at the institution were 
conducted. Five open-ended questions pertaining to perceived eating habits with an 
emphasis on protein were asked in both groups (Appendix N). Participants were asked to 
remain confidential during the session. The purpose and logistics of the discussion along 
with privacy and confidentiality were also discussed (See Section 3.9 Privacy and 
Confidentiality for details).  
3.7.1 Focus groups 
Guidelines for conducting focus groups were adopted from Best and colleagues (69) 
(initially adopted from Morgan (92), Barret (93) and Kreuger (94)). As per these
43 
guidelines, focus groups were conducted in the community by a facilitator (N.C or 
J.M) and a note taker (E.F or S.C) in a small private room. A list of questions
regarding nutrition and protein intake were supplemented with probing questions to
understand the participants’ perceived ideas on protein and general nutrition knowledge
(Appendix N). Focus groups started with general questions and probing questions were
only used to elicit a deeper response when needed. Focus groups were given a time
frame of 50 minutes (depending on the level of participation in each group). Focus
group 1 had 5 participants and lasted for 23 minutes, focus group 2 had 3 participants
and lasted for 35 minutes, focus group 3 had 5 participants and lasted for 23
minutes and focus group 4 had 4 participants and lasted 12 minutes. Focus groups
were audio-recorded using two recording devices. N.C transcribed the audio
recordings.
3.7.2 Individual Interviews 
Individual interviews were conducted at the long-term care home following 
permission from the staff RD. Individual interview guidelines were adopted from 
Reichstadt and colleagues (95). As per these guidelines, interviews were 
conducted by one trained researcher (N.C) in the participant’s own room. A list of 
questions regarding nutrition and protein intake were supplemented with probing 
questions to understand the participants’ perceived ideas of protein and general 
nutrition knowledge (Appendix N). Interviews started with general questions and 
probing questions were only used to elicit a deeper response when needed. 
Interviews were given a time frame of 50 minutes (depending on the level of 
participation of the individual and his/her capacity to answer each 
question). Interview 1 lasted 8 minutes, interview 2 lasted 22 minutes, interview 3 lasted 
25 minutes and interview 4 lasted 36 minutes. Interviews were audio-recorded using 
two different recording devices. N.C transcribed the audio recordings. 
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3.8  Statistical Analysis 
Quantitative data were inputted into an Excel spreadsheet then further transferred into 
a SPSS software (Version 25). Intra-Class-Correlation (ICC) scores for inter- and 
intra-rater reliability were calculated for research personnel based on 
measurements of QMLT on healthy individuals (done prior to data collection). 
Descriptive statistics were calculated for physical characteristics such as age, sex, 
height, weight, and BMI. A Shapiro-Wilk test was initially run to deduce 
normalcy of variables. A bivariate analysis using Independent T-tests was 
conducted to compare QMLT size with SGA and QMLT size with group. 
Similarly, a bivariate analysis using Pearson correlation coefficients was used 
when comparing continuous variables (QMLT with HGS, protein intake and FM). 
Additionally a multiple regression analysis was conducted to determine the best 
predictors of QMLT amongst variables that displayed significant correlations. 
The chi-squared test was used on categorical variables such as total participants 
meeting guidelines (categorized by “adequate, “under”, or “over”), as well as to 
determine the association of SGA scores (categorized as “A”, “B” or “C”) and group 
(institution versus community). 
As for qualitative data, N.C transcribed and analyzed both the focus groups and 
interviews verbatim. The type of qualitative data analysis used was the constant 
comparative method, in which quotations are chosen as a representation of each theme 
(96). Using a grounded theory approach, emerging themes were identified based on 
repeated patterns of response, were coded to create broad groups and then further 
divided into sub categories (97). Many other quotations that fell within the same 
category were grouped into similar themes until only major themes were obtained. 
Quotes that fit each theme were selected, totaling 2–4 quotes per theme (97). 
Data saturation was would be reached once no further themes could be identified 
(98). 
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3.9  Privacy and Confidentiality 
Participants were provided letters of information outlining the study, along with 
having the opportunity to ask any questions. Participants were required to sign a consent 
form to participate in the study. The letter of information outlined the purpose of 
the study, risks and benefits, privacy and confidentiality, along with information on 
voluntary participation and the right to refuse involvement at any point 
(Appendix C). Partial date of birth, first and last name (institution and community), 
and phone number (community only) were obtained from all participants. A list of 
residents eligible for the study from McGarrell was given to the PI in the form of a 
hard copy. The PI and co-investigators transferred all hard copy files from the 
long-term care home and community to Brescia University College. All original 
hard copies were kept in a locked cabinet in the Principal Investigator’s office and 
locked at all times.  
Directly after recruitment and consent, participants were assigned a 
study number, which contained information with no personal identifiers other than 
age and sex. Data without identifiers were stored on an encrypted USB drive. 
This drive was encrypted using UWO TrueCrypt and was password 
protected. Transcribed audio from focus groups and individual interviews 
contained no personal identifiers and all files were saved on to the same 
password-protected USB drive. All study data (raw and electronic via USB 
drive) were stored in a locked file cabinet in a locked office and any material 
that was transferred from the long-term care home and community to 
Brescia University College was completed only with the participant 
study number. Study data will be kept for 5 years in accordance with the 
WHSREB. Study data will be destroyed by shredding. Data on USB drives 
will be removed and the drive will be reformatted.    
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No agencies/groups/persons outside of the local research team other than the 
WHSREB have access to the identifiable data. 
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Chapter 4 
4  Results 
The following chapter will address subjects’ descriptive characteristics and results of the 
quantitative and qualitative analysis. 
4.1  Descriptive Characteristics 
Table 1 provides a summary of details on age, height, weight, BMI, and level of 
ambulation for each group. A total of 63 participants were recruited from June 2015 
to September 2017 for the study: 40 institutionalized (12 males, 28 females) 
and 23 community-dwelling older adults (5 males and 18 females). The average 
age of community-dwelling participants was 79 ± 6 years, which was 
significantly lower than the average age in the institution (84 ± 9 years; 
p=0.006). Overall, the youngest participant was 65 and the oldest was 101 
years of age. The average BMI for males was 25.4 kg/m2 ± 3.98 (19.7–29.4) 
in the community and 27.3 kg/m2 ± 4.67 (20.2–37.4) in the institution.
The average BMI for females was 27.6 kg/m2 ± 7.09 (17.3–40.1) in the
community and 26.6 kg/m2 ± 6.97 (15.0–43.1) in the institution. No
significant differences were observed between the community and institution with 
height, weight, and BMI (p=0.158, p=0.986, p=0.535, respectively).  
Out of 23 participants in the community, 21 of them were fully ambulatory and 2 
required an assisted walking device.  In the institution, 12 participants were fully 
ambulatory, 19 required an assistive walking device, and 9 were using a 
wheelchair/walker for mobility. Level of ambulation was significantly different  
(p<0.0001) between groups, showing that institutionalized individuals required more 
ambulatory device assistance than community-dwelling older adults. 
Table 1: Participant characteristics
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160.7 ± 6.10 
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4.2  Quantitative Analysis 
4.2.1 Distribution analysis 
All variables were verified for normality using the Shapiro-Wilk’s test. Our 
outcome variable, QMLT, in the community and institution showed normal 
distribution (p<0.05; data not shown); therefore, normality was assumed.  
4.2.2 Differences in average QMLT 
Table 2 summarizes the results of average QMLT size between the community and 
institution. Overall, no significant difference was found in average QMLT size between 
the community-dwelling (2.73 cm ± 0.81) and institutionalized participants 
(2.53 cm ± 0.86; p=0.358).  
4.2.3 Differences in Handgrip Strength (HGS) 
Table 2 summarizes the results of HGS between the community-dwelling and 
institutionalized participants. Community-dwelling participants displayed significantly 
higher HGS (59.2lbs ± 16.7) when compared to institutionalized 
participants (40.6lbs ± 18.2;  p<0.001). 
4.2.4 Differences in Fat Mass (FM) percentage 
Table 2 summarizes the results of FM percentage between the community and 
institution. No statistical significance was seen overall between the 
community-dwelling  (41.2% ± 8.10) and institutionalized participants (39.8% ± 
8.46; p=0.528).  
4.2.5 Differences in protein intake 
Table 2 summarizes the results of total protein intake between the community and 
institution. No statistical significance was identified between the community-dwelling 
(1.05g/kg/d ± 0.35) and institutionalized participants (0.99g/kg/d ± 0.31; p=0.491). 
Table 2: D
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2.73 ± 0.81 (1.18–4.41)
59.2 ± 16.7 (35–105)
41.2 ± 8.10 (25.3–52.8)
1.05 ± 0.35 (0.57–1.76)
2.53 ± 0.86 (0.77–4.08)
40.6 ± 18.2 (7–100)
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91 (21)
9 (2)
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25 (10)
0 (0)
0.096
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4.2.6 Differences in SGA scores 
Table 2 summarizes the results of SGA scores between the community and institution. 
When categorizing participants based on their given SGA scores, 91% and 9% 
of community-dwelling participants and 75% and 25% of institutionalized participants 
scored “A” and “B”, respectively (Table 2, Fig. 3). Therefore, a majority of participants 
overall were considered well-nourished. When analyzing differences in SGA scores 
between groups, no statistical significance was identified (p=0.096). Therefore, when 
controlling for all other variables, SGA scores were not significantly different 
between community-dwelling and institutionalized older adults.
4.2.7 Ability of variables to predict QMLT size 
Once a bivariate analysis was conducted of all variables with QMLT size (Fig. 4), 
correlations were then analyzed in a multiple regression analysis (Table 3). These 
included protein intake, HGS and SGA. Group was also included in the regression 
analysis (although it did not provide any significant correlations) in order to evaluate its 
effect on QMLT size while controlling for other variables. Table 3 summarizes the ability 
of variables to predict QMLT size. Overall, a moderate positive correlation was found 
with QMLT (cm) and HGS (lb) (b=0.319, r(63)=0.432, p=0.014) and a moderate negative 
correlation was found with QMLT (cm) and protein intake (g/kg/d) (b=-0.229, 
r(63)=-0.361, p=0.045). SGA scores also significantly predicted QMLT size (b=-0.303, 
p=0.012). The best predictor of QMLT size when controlling for all other variables was 
HGS (b= 0.319, r(63)=0.432, p=0.014). Therefore, QMLT size increased with greater 
HGS and higher SGA scores and decreased with higher protein intake. Additionally, out 
of all of the variables measured, HGS was the best predictor of QMLT size in both 
institutionalized and community-dwelling older adults. 
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4.2.8 Descriptive results of study subjects meeting guidelines 
Based on current evidence, guidelines were developed based for males and females 65 
years of age and older to identify individuals not meeting their recommended guidelines 
of HGS, FM percentage, and total protein intake (Table 4). These guidelines included cut 
off-points for HGS (1), FM percentage (See appendix O), and protein intake based on 
newly-published guidelines (1.0–1.5g/kg/d) (14). Total number and percentage of 
participants meeting guidelines are provided in Table 5 and Figure 3. Categories of each 
guideline were divided into “adequate, under, and over”. 
4.2.8.1 Handgrip Strength (HGS) 
When categorizing all participants based on HGS scoring, 91% of participants in the 
community met the recommendations, while only 9% were considered under. 
Alternatively, 47% of participants in the institution met their recommendations for 
HGS overall, while 53% were considered under (p<0.0001). Therefore, 
community-dwelling participants were more likely to meet the HGS guidelines when 
compared to participants in the institution.  
4.2.8.2 Fat mass (FM) percentage 
Both the community-dwelling and institutionalized participants were almost 
identical when it came to meeting their guidelines based on Bodystat protocol 
(Appendix O). Overall, 91% of community-dwelling participants and 93% of 
institutionalized participants were considered over their recommended FM 
percentage. Thus, no significant difference was observed between groups (p=0.867) 
and most individuals were over their FM percentage guidelines.  
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4.2.8.3 Total protein intake 
Community-dwelling and institutionalized older adults tended to have similar 
results when meeting their protein needs. Most community-dwelling 
participants (43%) were considered “adequate” (within 1.0–1.5g/kg/d), which was 
similar to that seen in the institution (45%). Additionally, 48% of community 
and 53% of institutionalized participants were under their recommendations for 
total protein intake (p=0.551) Therefore, both groups were largely considered 
consuming “adequate” or “under” their protein requirements based the 
aforementioned newly-recommended guidelines (14).  
4.2.9 Reproducibility of measuring QMLT using US 
Results from the reliability test conducted by research volunteers on young healthy adults 
prior to the study reveal excellent overall inter- and intra- rater reliability (Table 6). Of 7 
subjects and 3 researchers, overall Interclass Correlation Coefficient (ICC) scores for 
inter-rater reliability were 0.969 and 0.954 on the left and right leg, 
respectively (p<0.0001). Similarly, ICC scores for intra-rater reliability were 
0.998 and 0.986 (p<0.0001) on the left and right leg, respectively.  Therefore, 
researchers involved in taking the QMLT measurements using US had very low 
within and between-subject variance and excellent reproducibility.
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4.3  Qualitative Analysis  
4.3.1 Demographics and lifestyle characteristics 
A total of 16 (4 male and 12 female participants) took part in the 4 focus groups in the 
community. A total of 4 (3 female and 1 male) individual interviews were 
conducted at the institution. All individuals at the institution had meals and 
snacks provided by the long-term care home. In the community, 5 individuals 
from all focus groups had all meals provided to them by their retirement 
residence and 2 participants received half their meals served from the residence 
and half home-cooked. All other community-dwelling participants cooked at home. 
4.3.2 Analysis of themes from focus groups and interviews 
Participants in the focus groups and individual interviews responded to questions that 
initiated discussion surrounding protein intake. They discussed certain aspects of 
their lifestyle and eating habits, as well as why they may have found it difficult to be 
consuming adequate protein in their diet. 
Two major categories were created based on the information obtained from the focus 
groups and individual interviews: Eating patterns and reasons affecting protein 
intake. These categories were determined based on consistent patterns that emerged 
from both the community and institution. Major themes were further developed within 
each category and 2–4 quotes based on each theme were selected from transcribed 
data. Data saturation was not obtained due to small sample size and short 
discussions. A total of 10 major community and 7 major institution themes 
were identified. Table 7 and 8 summarize results of the community and 
institution qualitative analysis, respectively. 
Overall, focus groups in the community yielded common themes of eating 
patterns such as regimented/routine, grazing and a priority to eat healthy foods. These 
themes would depend on their eating environment, such as if they were served food 
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served food in a retirement home as opposed to cooking their own food. There was 
also a priority to eat healthy as well “I spent a lot of time finding clean food to eat”.  As 
for reasons affecting protein intake, these included food quality, cost of and access to 
protein-rich food, lack of knowledge, motivation, physiological changes with age 
and support to eat better. These themes included comments such as “It’s hard to know 
what is a protein…” and “I find it hard to make meals for one person”. 
Individual interviews in the institution provided similar themes with eating patterns such 
as regimented/routine due to their living environment and having meals served. 
However, mealtime setting played a major role in their eating patterns. For example, 
participants commented “I guess three set meals in a day better than when I was 
alone”, or “I can’t say that I eat because I’m hungry”. Reasons affecting protein 
intake in the institution also included lack of knowledge of protein-rich foods and 
physiological changes with age. Additional themes like meal likability, and 
trust in food environment also emerged as reasons affecting protein intake. One 
participant commented on how the plate is presented can affect meal likability 
“Attractiveness of the plate is really important”. Trust in the food environment 
was common in institutionalized older adults “The menu is made up by a dietitian 
so I’m assuming that the food we’re given have adequate protein”. 
In general, common themes amongst both groups include regimented/routine-eating 
patterns, lack of knowledge of protein-rich foods, and physiological changes 
with age. 
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Chapter 5 
5  Discussion 
The following chapter will interpret and describe the significance of both 
quantitative and qualitative findings from chapter 4.  
The objective of this study was to determine whether there was an association of specific 
risk factors for low muscle mass such as HGS, FM percentage, protein intake, and 
SGA, and the size of QMLT in community-dwelling and institutionalized older 
adults. Secondary information regarding participants' meeting established guidelines 
and the reliability of US measurement were included as an additional analysis. In 
accordance with our second objective, we examined perceived ideas regarding 
protein intake in both population groups to understand whether it can affect 
actual protein intake. Both quantitative (QMLT, HGS, protein intake, SGA status, 
and FM percentage) and qualitative (focus groups and individual interviews) data were 
analyzed. 
5.1  Review of Quantitative Data 
This section will discuss the significance of our quantitative findings in relation to current 
research. 
5.1.1 Insights into the demographic data 
Anthropometric measurements summarized include height, weight, and BMI. Along 
with anthropometric data, other characteristics evaluated were level of ambulation 
and age. Results showed that there were significant differences in both age (p=0.006) 
and level of ambulation (p<0.0001) between groups. Participants in the community 
were significantly more ambulatory than those residing in the institution (Table 1); 
however, differences in age and environment may have influenced these 
findings. The average age in the institution (84 ± 9 years) was significantly 
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higher than that of the community (79 ± 6 years; p=0.006; Table 1), which has been 
shown to have an impact on overall gait speed and level of ambulation (99). This may be 
a result of participants in the institution having higher levels of physical and cognitive 
disabilities when compared to community-dwelling participants. According to the 
Ontario Long-Term Care Association, 85% of residents in institutions require extensive 
help with activities of daily living (getting out of the bed, toileting, eating, etc…), 90% 
have cognitive impairment and 40% require monitoring for acute medical conditions 
(100). Overall, increased age and physical/cognitive impairments when compared to the 
community may have contributed to the differences in level of ambulation seen in the 
institutionalized older adults, which may also influence other results further discussed.
5.1.2 Differences in QMLT size
When it came to identifying differences in QMLT size between groups, QMLT size was 
not statistically significant between community-dwelling and institutionalized older 
adults (p=0.358; Table 2). Possible reasons for lack of statistical significance may have 
been due to differences in sample size between each group, measurement error, and 
subject variability (101), which will be further discussed in the limitations section of this 
chapter. Interestingly, a more recent preliminary study found that sedentary older females 
living in an institutionalized setting had greater thigh muscle thickness measured by US 
when compared to sedentary females living independently (102). Additionally, these 
authors focused on females who were sedentary in both groups, which was not the case in 
our study.
This suggests that more research may deduce significant findings of QMLT differences 
between these population groups. Despite not finding a statistical significance between 
QMLT size and group, valuable information on average QMLT size can still be used to 
create cut-off points for US technology in the older adult population. 
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5.1.3 Differences in handgrip strength 
Overall, HGS was significantly higher in the community than in the institution (59.2lbs ± 
16.7, 40.6lbs ± 18.2, respectively; p<0.001; Table 2). Although physical activity was not 
evaluated in this study, it may have played a role in the level of muscle strength in both 
populations. A recent study looked at the link between HGS and physical activity in older 
adults (103). Of 203 older adults observed, there was a significant correlation (p=0.019) 
between the level of physical activity and HGS, suggesting that individuals who had 
decreased HGS had lower levels of physical activity (103). Since older adults living in 
institutions have been shown to be less physically active than community-dwelling older 
adults (104), this may explain the difference observed in our study. Although not 
measured for the purpose of this study, the level of frailty of older adults in the institution 
may also have affected HGS scores. As previously noted, the average age 
of institutionalized older adults was significantly higher when compared to community-
dwelling older adults (p=0.006; Table 1). Along with having more physical and cognitive 
complications, these factors may explain the lower HGS scores in the institutionalized 
group. Research has indicated that cognitive function, somatic co-morbidities (such as 
previous myocardial infarction and higher levels of C-reactive protein), and medical 
treatments can influence HGS in older adults (105). Additionally, low level of ambulation 
(using an assessment of gait) has been shown to contribute to decreased leg muscle 
strength (p<0.05) (106). This is in agreement with our findings where institutionalized 
older adults are significantly less ambulatory (p<0.0001; Table 1), thereby potentially 
explaining the significant reduction in HGS (p<0.001; Table 2). Additionally, strong 
differences in HGS between sexes have been reported in older adults, suggesting 
that variations amongst gender may also influence our findings (107, 108). Therefore, 
it is possible that additional factors that were not identified for the purpose of this study 
such as physical activity and level of frailty in terms of sex differences (107, 108) may 
have influenced the differences in HGS between the community-dwelling and 
institutionalized older adults overall.
5.1.4 Differences in fat mass (FM) percentage 
Although no statistical significance was found between the community-dwelling and 
institutionalized older adults with regards to FM percentage (p=0.528; Table 2), our 
results did not take into account sex differences between males and females. Research has 
identified that females tend to have lower levels of catecholamine mediated lipolysis 
(109, 110), free fatty acid release in upper body subcutaneous fat and basal fat oxidation 
(111), thus contributing to higher levels of fat storage in women (112). Additionally, 
when examining body composition using tools such as MRI and BIA, males typically 
have more muscle mass than females and females tend to have more percent body fat 
than males (113, 114). Therefore, FM percentage appears to be sex-specific, which may 
explain the lack of significance seen overall. Future analysis taking into account sex 
differences may provide more significant findings on differences in FM percentage.  
5.1.5 Differences in protein intake 
No statistical significance was found in protein intake between groups (p=0.491). A study 
conducted by Tieland and colleagues (15) assessed dietary protein intake in healthy and 
frail older adults in the community, as well as institutionalized older adults. These 
authors found that healthy older adults in the community consumed significantly more 
protein when compared to frail older adults in the community and institutionalized older 
adults (p<0.001). Interestingly, this study also had similar findings to ours when it came 
to average protein intake in the community (1.1 g/kg/d ± 0.3 compared to 1.05 g/kg/d ± 
0.35 in this study), with greater differences observed in their institutionalized population 
(0.8 g/kg/d ± 0.3 compared to 0.99 g/kg/d ± 0.31 in this study). However, their study was 
conducted in the Netherlands and used a larger sample size (n=707), which may have 
contributed to the differences observed. Therefore, more research using a larger sample 
size may identify differences in protein intake between groups.
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5.1.6 Differences in SGA 
In our study, most participants (n=51) fell under the category of “well-nourished” 
according to SGA standards (Table 2 and Fig. 3). Although no significant differences in 
SGA scores between groups were observed (p=0.096), more participants scored an SGA 
score of “B” in the institution (25%) when compared to the community (9%; Table 2). 
This suggests that individuals in the institution show a higher tendency to be mildly 
malnourished than those in the community. Research studies have repeatedly shown the 
high risk of malnutrition in institutionalized older adults and the need for increased 
nutrition needs in this population (77-79). Particularly, older adults admitted to long-term 
care institutions can have many illnesses and complications such as dementia, depression, 
loss of autonomy with daily activities, the inability to feed themselves, as well as 
chewing/swallowing difficulties, along with the risk of drug-nutrient interactions from 
medications to treat co-morbidities (80, 81, 115). To avoid confounding our results, 
individuals with these complications were excluded from our study, as they did not meet 
the necessary criteria to conduct the measurements. It is important, however, to 
understand that malnutrition can still be prevalent overall in institutionalized settings. 
Based on SGA scores, most of our participants were considered well nourished at the 
time of recruitment; however, illnesses and age-related co-morbidities causing 
malnutrition may have an impact on these individuals later on. Interestingly, a 2015 
systematic review looked at the prevalence of malnutrition in Ontario long-term care 
homes in relation to food intake and swallowing impairments (dysphagia) (82). This 
study found that prevalence of dysphagia and malnutrition ranged from 7–40% and 12–
14%, respectively. The authors concluded that there are greater nutrition needs of 
institutionalized older adults (82). Therefore, long-term care organizations may need to 
be taking greater effort in ensuring their residents obtain appropriate nutrient intake to 
prevent malnutrition, as evidenced by the higher level of mildly malnourished individuals 
in the institution when compared to the community.
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5.1.7 Ability of variables to predict QMLT size 
5.1.7.1 QMLT and HGS 
Moderate positive correlations were found between QMLT and HGS (Fig. 4A; Table 
3). HGS was also shown to be the best predictor of QMLT size, regardless of group, but 
not controlling for age and sex. Therefore, individuals with higher HGS tend to have 
greater QMLT size. Our findings are consistent with other studies, suggesting that 
there is a relationship between muscle size and strength. For example, a 2014 study on 
318 community-dwelling older adults ≥65 years examined the relationship between 
muscle mass and strength using knee-extension to measure muscle strength and BIA 
to measure muscle mass (116). Individuals were divided both by sex and age group (65–
74, ≥ 75 years). Muscle mass and strength showed positive correlations in the older-
age category (>75 years) in both sexes, and in the younger age category of only men 
(116). Similarly, another study on 110 hospitalized older adults ≥60 years examined the 
association of muscle mass and strength (117). This study also found a moderate 
correlation between both measures; however, the accuracy of using muscle mass to 
predict strength was low (117). Both of these studies, however, determined that using 
muscle strength to predict muscle mass may be confounded by differences in age 
and sex, which may be an important consideration for our study. On the contrary, 
a 2013 study identified a direct correlation between muscle mass and strength 
independent of age and sex (118). This study used NHANES data from 2,647 men 
and women ages 50 and older using DXA to measure muscle mass, and HGS to 
measure muscle strength. Results found a positive correlation with muscle mass 
and strength overall, regardless of age and sex (118). Therefore, positive 
correlations can be seen between muscle mass and strength in older adults; 
however, due to inconsistencies between studies, more research is needed to develop 
a better understanding of the relationship between muscle mass and strength while 
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factoring in age and sex. Overall, our findings may provide more insight on the 
correlations between muscle strength and muscle mass in the older adult community.
5.1.7.2 QMLT and Protein Intake
Overall, we found that QMLT was moderately negatively correlated with protein intake 
(p=0.004; Fig. 4B; Table 3). Therefore, increased QMLT size is correlated with lower 
protein intake in older adults in this study. These results were surprising when compared 
to literature that supports the increasing need for protein to improve muscle mass (66-68). 
Our results provide similar findings when compared to another study suggesting protein 
supplementation beyond the current RDA of 0.8g/kg/d may not be necessary in lower 
functioning older men (59). Similarly, a 2014 meta-analysis assessed the ability of protein 
or amino acid supplementation and its effect on lean body mass and strength of leg 
muscles in a diverse older adult population (119). The authors concluded that, overall, the 
difference between control and treatment groups (participants supplemented with protein 
or amino acids) was not significant with regards to lean body mass (p=0.386) and strength 
(p=0.265 for leg extension, p=0.748 for double leg press). Generally, there is more 
evidence suggesting greater value of increased protein needs for muscle mass 
preservation in the older adult population. Our results, however, may have been 
influenced by food record observation accuracy as well as other variables not considered 
such as physical activity, energy intake, and age-related/ acute comorbidities. 
Additionally, as discussed in section 2.7.4, the type of protein consumed may affect the 
muscle size more than total protein consumed from food. Further research identifying 
protein quality while considering these other variables may provide more explanation of 
its effect on muscle mass.
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5.1.7.3 QMLT and SGA  
Our analysis also found that SGA score was a strong predictor of QMLT 
size, showing moderately positive correlations between variables (Fig. 4C; 
Table 3). Therefore, higher SGA scores were significantly associated with greater 
QMLT size when controlling for all other variables. These results are consistent 
with other studies that have shown the association with nutrition status and 
muscle size. One recent 2017 study identified that among 378 hospitalized older 
adults >70 years, higher risk of malnutrition using Short Nutritional Assessment 
Questionnaire (SNAQ) was associated with lower absolute skeletal muscle-, 
appendicular lean- and fat free mass measured by BIA (120). Another study 
identified the association of specific nutritional parameters of malnutrition (using 
SNAQ) with muscle mass in 185 geriatric outpatients (121). Reijnierse and colleagues 
found that loss of appetite and being underweight were the most strongly 
associated with lower total LMM after adjusting for age and fat mass (121). 
Therefore, these malnutrition parameters may explain lower muscle size in older adults. 
Although our study did not identify these specific markers, we had similar findings in the 
association of lower nutritional status and decreased muscle size. Additionally, our study 
differs from other research in that SGA is used as the malnutrition assessment tool. There 
have been no studies particularly using SGA to measure malnutrition while using US to 
measure QMLT. Therefore, our results provide novel conclusions regarding the 
associations of SGA with QMLT size and can be used in future research identifying links 
between malnutrition and muscle mass. 
5.1.8 Subjects meeting recommended guidelines for handgrip strength, fat mass 
percentage and protein intake 
5.1.8.1 Handgrip Strength (HGS) 
Results indicated that amongst both groups, community subjects tended to be above their 
guidelines for HGS, whereas most individuals in the institution were below their
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guidelines for HGS (Table 5; Fig. 3). Reasons for these differences have been previously 
discussed in section 5.1.3. This information can be important in determining populations 
at risk of sarcopenia and how lifestyle factors can play a role in muscle strength. Having 
lower muscle strength has been linked to an elevated risk of all-cause mortality (122). 
According to a recent study in 2018 by Li and colleagues (122) conducted on 4,449 
subjects over the age of 50, low muscle strength without the association of muscle mass, 
was linked to all-cause mortality. Although both muscle mass and strength were 
measured, only muscle strength obtained significant correlations with all-cause mortality 
associated with metabolic syndrome. The authors suggested that muscle strength might 
be a more important indicator of predicting age-related health outcomes in older adults 
(122). These results are consistent with a similar preceding study conducted in 2006 that 
looked at the correlation of muscle mass and strength with mortality and health in 2,292 
subjects aged ≥70 years (123). More recently, Newman and colleagues (124) concluded 
that muscle strength was strongly linked to increased mortality, which was not the case 
for muscle mass. Therefore, although not measured for the purpose of this study, 
institutionalized individuals may be at a higher risk of all-cause mortality due to 
decreased muscle strength.   
5.1.8.2 Fat mass (FM) percentage 
Similar to decreased muscle mass and strength, increased FM percentage can also be 
a risk factor associated with sarcopenia. Results from our analysis indicated that 
most individuals, regardless of living environment, were meeting above their 
guidelines for FM percentage based on BodyStat research cut-off points (Table 4, 
Appendix O). Although physiological changes with age can result in increased body fat 
and lower SMM (125), higher FM percentages may place older individuals at risk of 
complications due to sarcopenic obesity. As discussed in section 2.10, sarcopenic 
obesity is associated with increased risks of disability, primarily caused by 
higher rates of cardiovascular disease (126). 
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Recent research has identified that older adults classified with sarcopenic obesity had the 
highest rates of disability when compared to people with just sarcopenia (126). Similarly, 
Tyrovolas and colleagues (127) identified that an increase in muscle mass was 
positively associated with successful aging where an increased body 
fat percentage was inversely associated. These studies concluded that higher rates 
of FM percentage could result in a lower quality of life for older adults. Our study has 
identified that regardless of living environment, older adults in our sample 
were above their recommended FM percent ranges. Although not definitive, 
this might result in increased rates of disability and mortality. 
5.1.8.3 Protein intake 
Our results indicated that both groups had a higher percentage of individuals who 
were not meeting their required protein intake based on new proposed guidelines (1.0–
1.5g/kg/d; Table 4, 5; Fig. 3). Factors associated with changes in age such as 
reduced appetite and changes in taste and smell can all lead to limited food choices 
and lower intake of protein-rich foods (16). More notably, a large percentage of 
institutionalized and community-dwelling older adults not meeting their needs for 
protein is significant when addressing overall health. Data from NHANES 2005–
2006 showed that a large proportion of male and female older adults (5–12% and 
20–204%, respectively) were consuming below their requirements for protein 
when using 0.66g/kg/d as a guideline (128). As addressed in section 2.7.3, 
growing evidence suggests the need for higher amounts of protein for older adults in 
light of its role in preserving muscle mass (66-68, 129). A 2015 review on 
protein intake and muscle function addressed the importance of increased 
protein needs (consuming more than 1.0g/kg/d or 20–30g/meal) for older adults to 
improve protein synthesis and functional outcomes (130). However, some new 
research is challenging the need for increased protein beyond the current RDA for 
certain older adult populations (59, 119). 
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Therefore, interventions in the older adult population may be necessary when 
considering protein intake and its effect on quality of life; however, research is still 
ongoing in the effects of increased protein in all old-age population groups. 
5.1.9 Reliability of US to measure QMLT 
As stated previously, US has been shown to be a new tool for measuring 
muscle mass and has only recently been validated for use in research studies (6). The 
aim of using US in this study was to use this new technology and measure muscle 
mass in two population groups of older adults, which has never been done before. 
To examine the reliability of US to measure QMLT, inter- and intra-rater 
reliability on healthy volunteers were conducted (Table 6). This was used to 
determine the level of accuracy and reproducibility of using US within and 
between subjects. All research personnel demonstrated excellent inter/intra rater 
reliability (Table 6).  
One major obstacle for measuring QMLT using US was the level of 
compressibility when taking the measurements. Previous studies have not been able to 
come up with a universal approach for compressibility of the probe when measuring 
muscle mass using US. Research has shown both maximal and minimal 
compression to be effective as long as the chosen compressibility is consistent 
throughout obtaining the measurements (43-49). We trialled both methods on 
volunteers before the study and found that maximal compression was yielding less 
accurate results when taking repeated measurements as well as compromising muscle 
size due to the pressure of the probe on the skin. Therefore, minimal compression 
was used, as we found it to be the easiest to reproduce over multiple measurements 
and the best way to accurately measure the size of the muscle.  
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In general, our research further restates the reliability and reproducibility of 
measuring muscle mass, specifically QMLT, using US, which can be used as a 
potential method for future studies to develop cut-off points for muscle mass in the 
older adult population. 
5.2  Review of Qualitative Data 
This section will discuss results from the community and institution, and 
categories including eating patterns and reasons affecting protein intake.  
5.2.1 Eating patterns 
Three major themes were obtained from the community relating to eating patterns and 
included regimented/routine eating, grazing, and a priority to eat healthy food. The major 
themes taken from the institution-included regimented/routine, social mealtime setting 
and eating with no hunger cues.
Individuals who were consuming a more regimented/routine style of eating were having 
most or all of their meals provided to them by their residence regardless of living 
environment. We observed this in some locations in the community (where meals 
were served) and within the institution. These individuals felt that it would be better than 
being on their own because meals were served at regular times daily. This creates a 
greater need for healthcare providers in residences and institutions to ensure individuals 
are meeting their nutritional requirements at mealtimes. As seen in our quantitative 
results of protein intake, institutionalized older adults may not be receiving enough 
protein from their prepared meals; however, residents in long-term care expect they 
are meeting their nutritional needs from foods provided to them. Thus, it is imperative 
that institutions ensure their residents meet their adequate needs of protein to prevent 
morbidity and mortality associated with inadequate nutrition. Alternatively in the 
institution, eating in a social setting and having meals served were found to be 
positive aspects of their living environment. One participant commented that he/
she felt their eating patterns improved when moving into an institution ("I guess three set 
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meals in a day better then when I was alone.”). Research has demonstrated that men and 
women tend to have a higher food intake when eating with others over eating alone 
(131, 132). Therefore, consuming meals in social settings and/or having meals served 
may have an impact on overall food consumption in older adults and is an important 
consideration when identifying barriers to food consumption. Interestingly, 
participants also commented that because of these set meal times, they never felt 
hunger cues and ate because it was “mealtime”. Although this may help ensure 
adequate food intake in institutionalized older adults, some may feel pressured to 
eat more than their usual intake or lack enjoyment associated with food, which 
are also important factors in considering overall quality of life.  
Alternatively, community-dwelling participants living on their own had more of a 
tendency to graze instead of having set meals, which was one of the themes found 
from the focus group discussion. Due to the fact that many of the 
community-dwelling individuals stated that they lived alone or with a partner, 
there was no desire to cook large meals. Living alone increases in prevalence with 
age. Research has indicated with regards to loneliness, older women report less 
enjoyment with cooking and older men report higher use of ready-made meals, 
which can increase the risk of unhealthy habits (69), however, community-dwelling 
participants also discussed the importance of prioritizing nutritious, fresh food in 
their diet in order to obtain adequate health. Some strategies reported to 
help older adults increase their consumption of nutritious foods include 
encouraging pre-cooked or easy-to-prepare protein-rich foods that include frozen 
and canned foods, supported by easy recipes (17).  
Overall, it is important to ensure adequate nutrition by health-care professionals in 
living environments where meals are served. Additionally, older adults living in the 
community that cook and prepare meals for themselves may be at risk of under-
nutrition due to loneliness and the lack of desire to cook. Many strategies exist to help  
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increase consumption of protein-rich foods in the older adult population and 
should be implemented by health-care professionals to aid in increasing protein 
intake.  
5.2.2 Reasons for increased or decreased protein consumption 
Several themes were identified within the community group when compared to 
individuals in the institution with regards to protein consumption. Community-
dwelling older adults had more barriers to protein consumption due to their living 
environment. Since many community-dwelling older adults prepared meals for 
themselves, barriers such as food quality, cost, access, and motivation to cook 
protein-rich foods were common. These results are consistent with previous 
studies that also identified similar barriers to food intake that have 
been discussed in section 2.7 (69, 131, 133). 
Community-dwelling older adults felt that fresh and high-quality food was very 
important; however, this translated to a higher financial burden for 
many individuals. Some strategies to mitigate this include using 
healthcare professionals to educate individuals on perceptions of healthy and 
unhealthy foods. This includes teaching methods of purchasing healthy protein-rich 
foods on a budget and helping older adults better understand how to preserve fresh 
protein-rich foods by freezing them (17). 
A lack of motivation for cooking was also a common theme in the community. As 
previously discussed, cooking for one was commonly mentioned as a barrier to 
consuming enough protein, as individuals found it discouraging to cook full meals for 
just themselves and were fearful of items spoiling quickly. They also 
mentioned feeling “overwhelmed” with grocery shopping and would typically 
purchase the same items consistently to avoid spoilage of foods. This may result in a 
lower nutritional intake due to lack of variety of foods consumed (134). 
Appropriate education on healthy protein-rich foods, easy-recipes for one, and 
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obtaining access to grocery store tours may help increase variety of protein-rich foods, 
reduce food spoilage and increase confidence in cooking in the older-adult community. 
Additionally, difficulty getting to grocery stores was also a barrier identified to 
obtaining adequate foods when discussing the limitations of transportation to 
grocery stores. It is suggested that suitable bus routes to improve accessibility to 
food outlets and successful meal-delivery systems may help increase food intake in the 
older adult community (69). 
Lack of knowledge of protein-rich foods as well as physiological changes with age 
were common amongst both community and institutionalized older adults. When 
questions regarding naming protein-rich foods were asked, most participants 
seemed to lack the appropriate knowledge of foods that contained protein. As 
previously mentioned, increasing knowledge of protein-rich foods by health-care 
professionals in the institution and community may help older adults obtain better 
variety and increase consumption of protein (17). 
Most participants also stated that natural physiological changes with age such as sensory 
perceptions of food, chewing and swallowing difficulties, and loss of appetite 
were reasons that would prevent them from eating protein-rich foods. These 
results are also consistent with Best and colleagues' study that identified 
physiological barriers with age (69). These functional changes can have an impact 
on consumption of certain protein-rich foods such as meat and nuts, which may 
lead to decreased protein consumption overall (69). A recent 2017 study has also 
shown that poor appetite in older adults was associated with a significantly 
lower consumption of protein-rich foods, whole grains, fruits, vegetables, 
fibre and solid foods (135). Therefore, the physiological changes associated 
with age are an important consideration when acknowledging protein 
consumption.
Themes such as meal likability and trust in the food environment were also 
identified in the institutionalized group. Although institutionalized individuals usually
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have very little choice with their meal consumption, as we have discussed previously, 
they tend to trust that they are receiving enough nutrition from their meals. They felt 
that because a dietitian helped develop their meals, they did not have to be concerned 
with their intake. As we have seen in the analysis of protein intake in the 
institution, many individuals in this environment may not be obtaining adequate 
protein, and greater evaluation of protein content in the meals provided is 
warranted.  
Meal likability was also associated with the attractiveness of the meal. Meals that did 
not look “appetizing” were typically not chosen or fully consumed by the individual. 
Comments concerning the way the protein was cooked also came up (“It is their 
cooking method, yes. It’s a silly thing.”). Other qualitative studies have also found that 
meal-likability was a common concern amongst older adults (16, 17, 69). Strategies that 
were discussed to improve consumption of protein-rich foods included promoting 
complementary condiments and added flavors, as well as creating more involvement 
in recipe development in residences through use of tasting sessions (17). Thus, there is 
a need for intervention in long-term care homes to promote higher protein intake 
through meal attractiveness. Additionally, greater support is needed in the community 
to promote increased intake of protein-rich foods. 
Overall, there is a need for increased education and access to regulated health 
professionals such as Registered Dietitians to help increase overall nutrition 
knowledge. Consequently, this would assist in promoting more information on 
healthy sources of protein and easy cooking methods to encourage higher intake of 
nutritionally adequate foods. In general, lack of knowledge, physiological changes 
with age and lifestyle barriers can prevent older adults from obtaining adequate 
protein intake, and nutrition overall. Promoting more knowledge using 
dietetic education services, ensuring meal like-ability in residence settings, 
improving social environments and better access to nutritionally-adequate foods may help 
increase overall protein consumption in the older adult community.   
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5.3  Study Implications  
We have been able to measure QMLT using a novel approach of ultrasonography while 
ensuring strong reliability. We have also been able to understand the relationship of FM 
percentage, nutritional status, protein intake, muscle strength, and living environment on 
QMLT size in older adults. With this, we have identified significant differences in these 
variables between groups for HGS, as well as significant associations of SGA, HGS and 
protein intake with QMLT size amongst our sample group. We were also able to 
determine how many of our participants were meeting their recommended guidelines 
based on current research to better understand potential risks of individuals in both 
institutionalized and community based settings. Finally, we were able to identify themes 
relating to eating patterns and reasons affecting protein intake in both community-
dwelling and institutionalized older adults. Despite many strengths and obtaining 
valuable information from our research, some limitations and obstacles encountered need 
to be addressed.
5.3.1 Limitations and obstacles encountered in our study
One major limitation of this study was the sample size, which may have resulted in our 
study being underpowered when conducting statistical analysis. To obtain more valuable 
information from a regression analysis, a larger sample size would be required. We had 
initially calculated a total of 75 participants for the study; however, we only recruited 63. 
We did encounter a few difficulties when recruiting participants for the study that made it 
difficult to reach our desired sample size. One reason may have been due to the lack of 
monetary compensation for participation in our study. Although incentives can assist in 
increasing recruitment, many disadvantages include increased cost to the study and the 
potential inducements to participate in a study only for its incentive provided (136).
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Research has also suggested that participants find payment incentives to be 
inappropriate for health related studies (137). Therefore, we are unsure if having 
incentives may have had an impact on overall recruitment, and whether this may 
have influenced our outcomes.  
Other limitations include generalizability and variability between groups. This study was 
conducted in Ontario, Canada and was geared to a population of older adults ages ≥65 
years. There was only one location for the institution compared to multiple locations in 
the community. A majority of participants were females, which created a very small 
sample size of males for analysis. There were a total of 5 males in the community and 10 
in the institution, which increased the likelihood of type-1 error in the statistical analysis. 
Additionally, the variability in sample size and gender between the community-dwelling 
and institutionalized group can influence the ability to determine 
clinical significance using forms of statistical analysis such as Cohen's effect 
size (138). There are a few reasons why we were more likely to recruit females than 
males. One reason may have been due to the higher age group for 
recruitment and the differences in life span between males and females (139). 
Females generally outlive males by 4–5 years (139). This can be due to 5 times 
higher mortality related to cardiovascular disease in men, and the endothelial 
function benefits of estrogen in women to preserve life span (139). Statistics Canada 
has also concluded that although 54.7% of the old-age population (>65 years of 
age) in 2015 was female, it is projected to increase over the next 15 years due 
to the “baby-boomers” generation (140). One study also discussed sex 
differences in participant recruitment and found an increased likelihood of 
females to participate in research studies over males (141). The major finding 
concluded a higher likelihood of males do not participate due to not wanting to 
invest their time in a study (26.3% males compared to 10.4% females) (141). 
Therefore, reasons such as females living longer than males and the likelihood of 
males not wanting to invest their time in the study may have been reasons for the 
lack of sex heterogeneity.  
82 
Measurement error may have also occurred when obtaining food intake through direct 
observation due to reporting bias from volunteers who were involved in food 
intake observation at the institution. The research team, however, was limited 
with how closely food intake could be observed and the ability to accurately 
record food portions due to ethical considerations at the institution. Initially, the 
research team wanted to measure food intake by removing consumed meals 
from the residents’ tables and record food proportions in a separate room. 
Residents and staff at the long-term care home expressed that they were not 
comfortable with this method, thus preventing us from ensuring greater accuracy. 
Therefore, it was required that we directly observe food intake of the resident by 
observing their consumption for all meals while providing some distance from the 
dining room. To maintain accuracy during this process, the primary researcher 
consistently audited volunteers’ food intake observations by ensuring volunteers 
were accurately reporting food quantities. Extensive training was provided to 
volunteers and only 5 total individuals (3 volunteers and 2 primary researchers) 
ended up directly observing institutionalized participants and inputting all the food 
intake data. These individuals were chosen due to their ability to accurately record and 
input the food intake data in the ESHA software.  
Additionally, self-reported data can also be a limitation due to the risk of error 
associated with having to recall information. Height, weight, and food intake were 
self-reported from the community. This may result in incomplete or inaccurate 
reporting due to participants not remembering height and weight or particular food/
beverages consumed, failure to record food intake in a timely manner, 
purposefully not recording data, and poor portion size estimates (142). To ensure 
more accurate reporting, detailed instructions were provided to each participant in 
the community on how to appropriately record food intake data. Participants were 
also provided an option to be called 3 days within a week for a 24-hour food recall 
of each day. An experienced research volunteer that had received 24-hour recall 
training conducted this. One last limitation was that our study was cross-sectional.
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This can pose disadvantages as it makes it impossible to analyze outcomes over a period 
of time. Additionally, cross sectional data may not provide an accurate representation of a 
population group due to the timing of this snapshot. Results of cross-sectional data cannot 
determine cause and effect; however, findings from this research can create a basis 
for more in-depth and longitudinal studies. 
Some limitations of our qualitative component include the short length of our focus 
groups and interviews, small sample of participants and lack of data on gender of 
participants in these groups, which can all impact inability to obtain data saturation. 
5.3.2 Strengths of the study 
Despite the limitations and obstacles within this study, there are strengths 
worth mentioning. A major strength was the ability for the study to use 
only validated measurement methods. These included HGS using a dynamometer, 
body composition using a BIA machine, US using a validated method of measurement, 
and a validated SGA form from the Canadian Malnutrition Task Force. Additionally, 
US was previously tested before use in the study to ensure high inter/intra-rater 
reliability and all quantitative measures were repeated multiple times to ensure accuracy.  
Another strength was that primary research personnel were Registered Dietitians and 
all other volunteers were extensively trained by the dietitians prior to collecting/
inputting any food intake data. Dietitians were able to obtain medical directives before 
conducting US measurements by physicians at the institution with the approval from the 
WREB. Our study also had a wide variety of older adults in the community, as 
recruitment took place in multiple locations. Furthermore, our study was not 
influenced by any other biases, motivations, or expectations from other parties. 
There is confidence in the ability to maintain strong scientific rigor using thorough 
analysis techniques, consistency and neutrality throughout the study.  
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Chapter 6 
6  Conclusion 
The following chapter will summarize key points from the study, discuss the relevance of 
this research to the dietetic profession, and provide recommendations of avenues for 
future research.
Our study found that amongst the independent variables (HGS, protein intake, SGA,
FM percentage, and group), HGS and SGA showed strong positive associations while 
protein intake showed a negative association with QMLT size. FM percentage and 
“group” (institutionalized or community-dwelling) did not provide any association. 
Additionally, although QMLT size was not significantly different between groups, HGS 
and descriptive characteristics including ambulation and age did provide significant 
results. These results identified that community-dwelling older adults were younger and 
tended to have higher HGS and levels of ambulation than those in the community. We 
also found that institutionalized older adults were significantly below their HGS 
guidelines and most of our study population was not meeting adequate protein needs 
based on updated guidelines for protein (1.0–1.5g/kg/d). Use of US technology was also 
tested in this study and showed promising results for inter- and intrarater reliability. 
Finally, qualitative results identified common themes regarding perception of protein 
amongst the community-dwelling and institutionalized older adults. These included 
regimented/routine-eating patterns, lack of knowledge of protein-rich foods, and 
physiological changes with age.
6.1 Relevance to the dietetic profession
Sarcopenia is a growing concern in the dietetic community. As previously discussed, 
sarcopenia is a common issue amongst older adults and a lack of intervention can lead to 
many long-term complications. Dietitians are involved in ensuring adequate 
85 
nutrition for older adults in long-term care homes and in the community and play a major 
role in preventing malnutrition. Malnutrition has been a known cause of increased rates 
of sarcopenia by causing decreased body weight, muscle mass, muscle strength, and 
overall physical function (4, 74). Older adults are at a higher risk of becoming 
malnourished due to decreased food intake from chewing/swallowing difficulties, illness, 
and/or chronic disease (78, 79, 81). A reduced consumption of predominantly protein can 
lead to major complications in muscle function (8), and, as we have seen, these nutrients 
can play a major role in muscle synthesis (8, 13). There has been debate over the 
appropriate amount of protein required for older adults. Many studies have suggested that 
older adults should obtain 1.0–1.2g/kg/d of protein for healthy individuals and 1.2–1.5g/
kg/d for those doing resistance/endurance training or who have an acute/chronic disease 
(14). Other studies have shown that the type of protein can also affect absorption and 
muscle synthesis (57, 59), and that protein supplementation may be useful in helping to 
reach these protein needs (61, 63-67, 119, 143). On the contrary, some limited studies 
dispute this and suggest that increase protein may not be required for certain populations 
(59, 119). As indicated in our study, institutionalized older adults do not tend to meet 
their needs of protein and older adults face many barriers to protein intake such as lack 
the knowledge, resources, and access to protein-rich foods. These are all implications that 
dietitians should be aware of when involved in generating long-term care home menus 
and providing education and nutrition services in institutions and the community. 
Other factors such as muscle strength, nutritional status, FM percentage and living 
environment may also play a role in the general health of older adults, and have the 
potential to affect muscle size. These complications can lead to increased rates of 
morbidity and mortality, decreased quality of life and a greater strain on the healthcare 
system (24). As the older adult population continues to grow, rates of sarcopenia will
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increase and become a major concern primarily in institutionalized settings due to higher 
rates of illness and chronic disease (79). Therefore, our research may provide new ways 
to detect sarcopenia as well as understand the impact of certain risk factors on muscle 
mass, which can assist clinicians in creating new guidelines to prevent such unfavorable 
outcomes.
6.2 Future directions
As we have also previously discussed, gaps still exist in sarcopenia research; however, 
US is a promising new method of detecting muscle loss in the older adult population (1, 
6). Although our study has not been able to identify significant differences in muscle size 
amongst community and institutionalized older adults, more research is required to 
develop appropriate cut-off points using US to measure QMLT. A larger sample 
population will help better understand the relationship of different variables and their 
effect on muscle size, help to identify clinical significance, and allow a better evaluation 
of differences based on sex. Longitudinal research can help identify how these risk 
factors can affect general health over a longer length of time. Longitudinal studies are 
essential in understanding the long-term effects of an outcome. In the case of this study, it 
would be interesting to re-evaluate participants after a year to measure changes of body 
composition, muscle mass and muscle strength with increasing age. It might also be 
beneficial to know if increasing protein intake of both community and institutionalized 
older adults can impact muscle mass over a longer period of time. Furthermore, 
longitudinal studies on the affect of educating older adults on protein-rich foods in the 
community might also help better understand if this approach can improve protein 
consumption in this population. 
Moreover, additional research on different factors such as nutrients not included in this 
analysis (i.e. calories, fat, vitamin D, and other micronutrients) and the impact of
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physical activity, which have been previously studied in other sarcopenia 
research (21), may also provide further insight to some of the results of our study. 
Similarly, studying specific amino acids such as leucine with the parameters 
measured in our study may provide more valuable information on the role of specified 
components of protein. 
Overall, our research has created a basis for future studies to use US as a tool for 
measuring QMLT, understand how certain risk factors can affect muscle size, 
determine the population of older adults not meeting recommended guidelines, 
and appreciate older adults’ perspectives on protein intake that can cause decreased 
consumption of protein-rich foods. More research in the area of sarcopenia prevention 
will help clinicians develop better resources to prevent or mitigate this debilitating 
condition, and reduce morbidity and mortality related to decreased muscle size and 
function. 
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Part 4 of the Natural Health Product Regulations, Health Canada Medical Device Regulations and Part C, 
Division 5, of the Food and Drug Regulations of Health Canada. 
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conditional to timely submission and acceptance of HSREB Continuing Ethics Review. 
The Western University HSREB operates in compliance with the Tri-Council Policy Statement 
Ethical Conduct for Research Involving Humans (TCPS2), the International Conference on 
Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use 
Guideline for Good Clinical Practice Practices (ICH E6 RI), the Ontario Personal Health 
Information Protection Act (PHIP A, 2004), Part 4 of the Natural Health Product Regulations, 
Health Canada Medical Device Regulations and Part C, Division 5, of the Food and Drug 
Regulations of Health Canada. 
Members of the HSREB who are named as Investigators in research studies do not participate in 
discussions related to, nor vote on such studies when they are presented to the REB. 
The HSREB is registered with the U.S. Depa1tment of Health & Human Services under the lRB 
registration number IRB 00000940. 
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Confidential  Agreement 
This is an agreement between ________________________________ and Dr. Madill and the 
Sarcopenia Research Team. 
By signing this agreement I  agree not to share any information pertaining to 
residents, participants or any other ethical issues regarding this project. I will not 
share any information regarding ethics approval, the ethics submission, the research 
proposal or any attachments related to the project. I will not discuss with anyone 
about any of the residents or participants personal information or any of their study 
data, with my colleagues or peers, at any time. I will also not counsel or make any 
nutrition related recommendations with any of the residents or participants at any 
time during this study as I acknowledge that I am not qualified to provide these 
services and doing so would be perceived as unethical. 
I acknowledge that completing any of the following offences list above will violate my 
contract with Dr. Madill and the Sarcopenia Research Team and I will be asked to 
remove myself from volunteering with this research project. Also, any information 
regarding my role with this research project will consequently be removed from my 
resume. 
Signature of Student: _________________________________ 
Signature of Witness: _________________________________ 
Date: __________________________ 
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Differences in quadriceps muscle layer thickness (QMLT) size 
and contributing risk factors in free-living and low-risk 
institutionalized older adults: A cross-sectional study 
LETTER OF INFORMATION - Community 
Name of Principal Investigator: Dr. Janet Madill, Professor of Foods and Nutrition, Brescia 
University College 
Co-Investigator (s): Nesrine Cheikh RD, DDEPT, MSc.FN (c), Amanda Dufault MSc.FN (c) 
Contact Information: Dr. Janet Madill 519-432-8353, extension 28240 (jmadill7@uwo.ca); 
Nesrine Cheikh (ncheikh2@uwo.ca), Amanda Dufault (adufault@uwo.ca)  
Introduction 
My name is Dr. Janet Madill and I am a Professor in the Foods and Nutrition Department at 
Brescia University College.  I am currently conducting research into the prevalence of sarcopenia 
in the elderly population, and would like to invite you to participate in this study.  The purpose of 
this information letter is to provide you with enough information for you to decide if you would 
like to participate in the study.   
Purpose of the study 
Sarcopenia is the loss of muscle mass and strength due to the natural aging process. The purpose 
of this study is to assess factors contributing to quadriceps muscle layer thickness (QMLT) size 
and health outcomes in free-living vs low-risk institutionalized older adults as there is currently 
little to no information available on this topic. The aim of the study is to obtain information 
regarding medical/physical history, nutrient intake, bioelectrical impedance analysis (BIA) and 
hand-grip strength to determine nutrition outcomes related to muscle mass. We aim to collect a 
total of 30 participants for this component of the study.  
Study Design/Procedures 
If you agree to participate in this study, research personnel will collect the following information 
at the community center or at your home, whichever you prefer: 
1. Ultrasound Sonography: we will measure your muscle mass using FUJIFILM SonoSite
Mturbo, a portable ultrasound machine. Ultrasound machines use high frequency sound waves
passed from the machine to the skin to create images so we are able to determine muscle mass.
For this study, we will be measuring the quadricep, a large leg muscle located on the front of the
thigh. You will be asked to wear shorts/skirt in order to conduct this measurement, which can be
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2. Handgrip Strength: We will also measure your muscle strength by using a dynanometer.
You will hold the dynamometer in your hand, with your arm at a right angle and your elbow by
your side. You will squeeze the dynamometer with maximum effort for about 5 seconds. This will
give us a measurement of your hand-grip strength. This procedure will take approximately 10
minutes to complete.
3. Bioelectrical Impedance Analysis (body fat percentage): BIA will measure total body
water in order to measure total body fat percentage in relation to lean body mass. Electrodes will
be placed on both hands and a small electric current will be sent through the body. This is a safe
procedure and works by passing a safe battery-generated signal through the body. Readings will
be taken three times with an average reading recorded. This procedure will take approximately
10 minutes to complete.
These procedures are painless and will take approximately 30 minutes to complete in total and 
will be done only once. 
4. Food intake:
We will review with you what you have eaten in the last 24-hours. We will also provide you with 
a 3-day food record sheet for you to take home and complete. We will review and explain how to 
fill in the food intake record. As well, we will record your height and weight. This process will 
take approximately one hour to complete. 
All testing will be completed during a scheduled session between you and the research personnel. 
The measurements along with the food intake review and discussion together should take 
approximately one and a half hours to complete in total. 
5. Focus group:
We will ask you to participate in one of the four focus groups we will be conducting in the
community but participation will be on a purely voluntary basis. You will meet in a group with
up to five participants and you will be asked to discuss the following topics: your eating patterns,
if you think you eat well, what, if any supports you  would need to help you eat better and if you
have any challenges to eating protein. Focus group discussions will be audio recorded to aid the
research team in their data collection.  You will be assigned a number which will be used by the
person writing the details of the focus group, to protect your privacy.  The audio recording will
only be initiated after introductions of the group.    No personal identifiers will be used. This
discussion should take approximately 50 minutes to complete.
Voluntary Participation 
Participation in this study is voluntary. You may refuse to participate, refuse to answer any 
questions or withdraw from the study at any time with no effect on your medical care.  Should 
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and relaxed and we will measure the midpoint of your quadricep. We will apply a gel to the 
surface of probe of the ultrasound machine, then gently press the probe against your skin. 
We will then capture an image and take a measurement electronically. This procedure will 
take approximately 10 minutes to complete. 
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you chose not to participate, any information about your study results will not be used. You will 
not waive any legal rights by participating in this study. You will not be compensated for your 
time should you choose to participate.  
Risks & Benefits 
The only risk associated with ultrasound is that the participant may be allergic to the gel used to 
conduct the measurement. Please consult the researcher if you are allergic to the gel or if you 
develop a rash after having the gel applied to you.The only inconvenience experienced will be 
that will be meeting with a member of the research team to discuss your weight history, and to 
talk about what you have eaten in the last 24 hours and to ask you to record what you eat for 3 
days. We will review with you how to complete these forms and provide you with the forms to 
use to record your food intake. There are no direct benefits, however, you are contributing to 
valuable research in the area of sarcopenia and to prevent and improve outcomes in those 
suffering with the condition.  
Confidentiality 
The information collected will be used for research purposes only, and neither your name nor 
information, which could identify you, will be used in any publication or presentation of the 
study results. All audio recording and typed transcripts and the interviewer’s notes will be 
securely locked in cabinet at Brescia University College, and only members of the research team 
will have access to it.  Typed transcripts will be stored on encrypted key. Once transcribed, all 
recordings will be erased. All consent forms will be kept in a locked cabinet file at Brescia 
University College. Study data will be destroyed after five years. All information collected for the 
study will be kept confidential. 
Questions 
If you have any questions about the conduct of this study or your rights as a research participant 
you may contact the Office of Research Ethics, Western University at 519-661-3036 or 
ethics@uwo.ca. If you have any questions about this study, please contact the principal 
investigator, Dr. Janet Madill, RD, 1285 Western Road, Brescia University College, London 
N6G 1H2, 519-432-8353 extension 28240, jmadill@uwo.ca, or the research associate (s) Nesrine 
Cheikh (ncheikh2@uwo.ca) and Amanda Dufault (adufault@uwo.ca)  
This letter is yours to keep for future reference. 
[Signature] 
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Differences in quadriceps muscle layer thickness (QMLT) size and 
contributing risk factors in free-living and low-risk institutionalized 
older adults: A cross-sectional study 
CONSENT FORM - Community 
Name of Principal Investigator: Dr. Janet Madill, Professor of Foods and Nutrition, Brescia 
University College 
Co-Investigators: Nesrine Cheikh, Amanda Dufault 
I have read the Letter of Information, have had the nature of the study explained to me and I 
agree to participate. All questions have been answered to my satisfaction. Please note you do not 
waive any legal rights by signing the consent form. 
   I choose to participate in the focus group 
Name (please print): 
Signature: Date: 
Name of Person Obtaining Informed Consent: 
Signature of Person Obtaining Informed Consent: 
Date: 
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Differences in quadriceps muscle layer thickness (QMLT) size 
and contributing risk factors in free-living and low-risk 
institutionalized older adults: A cross-sectional study 
LETTER OF INFORMATION-Institution 
Name of Principal Investigator: Dr. Janet Madill, Professor of Foods and Nutrition, Brescia 
University College 
Co-Investigator (s): Nesrine Cheikh RD, DDEPT, MSc.FN (c), Amanda Dufault MSc.FN (c) 
Contact Information: Dr. Janet Madill 519-432-8353, extension 28240 (jmadill7@uwo.ca); 
Nesrine Cheikh (ncheikh2@uwo.ca), Amanda Dufault (adufault@uwo.ca)  
Introduction 
My name is Dr. Janet Madill and I am a Professor in the Foods and Nutrition Department at 
Brescia University College.  I am currently conducting research into the prevalence of sarcopenia 
in the elderly population, and would like to invite you to participate in this study.  The purpose of 
this information letter is to provide you with enough information for you to decide if you would 
like to participate in the study.   
Purpose of the study 
Sarcopenia is the loss of muscle mass and strength due to the natural aging process. The purpose 
of this study is to assess factors contributing to quadriceps muscle layer thickness (QMLT) size 
and health outcomes in free-living vs low-risk institutionalized older adults as there is currently 
little to no information available on this topic. The aim of the study is to obtain information 
regarding medical/physical history, nutrient intake, bioelectrical impedance analysis (BIA) and 
hand-grip strength to determine nutrition outcomes related to muscle mass. We aim to collect a 
total of 45 participants for this component of the study. 
Study Design/Procedures 
If you agree to participate in this study, research personnel will collect the following information: 
1. Ultrasound Sonography: We will measure your muscle mass using FUJIFILM SonoSite
Mturbo, a portable ultrasound machine. Ultrasound machines use high frequency sound waves
passed from the machine to the skin to create images so we are able to determine muscle mass.
For this study, we will be measuring the quadricep, a large leg muscle located on the front of the
thigh. You will be asked to wear shorts/skirt underneath your clothing in order to conduct this
measurement. You will lie on your back comfortably in your bed, with your knee extended and
relaxed and we will measure the midpoint of your quadricep. We will apply a gel to the surface of
probe of the ultrasound machine, and then gently press the probe against your skin. We will then
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capture an image and take a measurement electronically. This procedure will take 5 
approximately minutes.  
2. Handgrip Strength: We will also measure your muscle strength by using a dynanometer.
You will hold the dynamometer in your hand, with your arm at a right angle and your elbow by
your side. You will squeeze the dynamometer with maximum effort for about 5 seconds. This will
give us a measurement of your hand-grip strength. This procedure will take approximately 10
minutes.
3. Bioelectrical Impedance Analysis (body fat percentage): BIA will measure total body
water in order to measure total body fat percentage in relation to lean body mass. Electrodes will
be placed on both hands and a small electric current will be sent through the body. This is a safe
procedure and works by passing a safe battery-generated signal through the body. Readings will
be taken three times with an average reading recorded. This procedure will take approximately 5
minutes.
These procedures are painless and will take 20 minutes to complete and be done only once. 
4. Food intake: We will record your food intake through direct observation during designated
meals and snacks.
5. Focus group or Individual Interviews: We will ask you to participate in one of four
focus groups or individual interviews we will be conducting at the McGarrell Place Long-Term
Care Home but participation will be on a pure voluntary basis.
Focus group: You will meet in a group with up to 4 other participants and will be asked to 
discuss the following topics: my eating patterns, if I think I eat well, what, if any supports I would 
need to help me eat better and if I have any challenges to eating protein. Focus group discussion 
will be audio recorded to aid the research team in their data collection. This discussion should 
take approximately 50 minutes to complete.  
Individual interviews: The researcher will meet with you on a one-to-one basis. You will be 
asked to discuss the following topics: my eating patterns, if I think I eat well, what, if any supports 
I would need to help me eat better and if I have any challenges to eating protein.  Individual 
sessions will take approximately 20-40 minutes each and will be conducted in the privacy of your 
own room at McGarrell Place. This discussion will be audio recorded to aid the research team in 
their data collection.  
Voluntary Participation 
Participation in this study is voluntary. You may refuse to participate, refuse to answer any 
questions or withdraw from the study at any time with no effect on your medical care.  Should 
you choose not to participate, any information about your study results will not be used. You will 
not waive any legal rights by signing this consent form. You will not be compensated for your 
time should you choose to participate.  
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Risks & Benefits 
The only risk associated with ultrasound is that the participant may be allergic to the gel used to 
conduct the measurement Please consult the researcher if you are allergic to the gel or if you 
develop a rash after having the gel applied to you. There is no direct benefit to the participant 
however, the participant is involved in contributing to valuable research in the area of sarcopenia 
and to prevent and improve outcomes in those suffering with the condition.  
Confidentiality 
The information collected will be used for research purposes only, and neither your name nor 
information, which could identify you, will be used in any publication or presentation of the 
study results. We will look in your medical records from the institution including your personal 
health information and we will collect only the information we need for this study. All audio 
recording obtained from the focus groups will contain no personal identifiers and will be saved 
initially on password protected personal devices. These recordings will then be permanently 
deleted after immediate transfer to a password protected flash drive that will remain in the in a 
locked cabinet file at Brescia University College for transcription purposes only.  All information 
collected for the study will be kept confidential.  All consent forms will be kept in a locked cabinet 
file at Brescia University College. Study data will be destroyed after five years.  
Questions 
If you have any questions about the conduct of this study or your rights as a research participant 
you may contact the Office of Research Ethics, Western University at 519-661-3036 or 
ethics@uwo.ca. If you have any questions about this study, please contact the principal 
investigator, Dr. Janet Madill, RD, 1285 Western Road, Brescia University College, London 
N6G 1H2, 519-432-8353 extension 28240, jmadill@uwo.ca, or the research associate (s) Nesrine 
Cheikh (ncheikh2@uwo.ca) and Amanda Dufault (adufault@uwo.ca)  
This letter is yours to keep for future reference. 
[Signature] 
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Differences in quadriceps muscle layer thickness (QMLT) size and 
contributing risk factors in free-living and low-risk institutionalized 
older adults: A cross-sectional study 
CONSENT FORM-Institution  
Name of Principal Investigator: Dr. Janet Madill, Professor of Foods and Nutrition, Brescia 
University College 
Co-Investigators: Nesrine Cheikh, Amanda Dufault 
I have read the Letter of Information, have had the nature of the study explained to me and I 
agree to participate. All questions have been answered to my satisfaction. Please note you do not 
waive any legal rights by signing the consent form.  
   I choose to participate in the focus group or individual interview 
Name (please print): 
Signature: Date: 
Name of Person Obtaining Informed Consent: 
Signature of Person Obtaining Informed Consent: 
Date: 
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PARTICIPANTS NEEDED FOR 
RESEARCH IN AGING AND MUSCLE LOSS 
We are looking for volunteers to take part in a study to 
examine changes in muscle mass who are aged 65 
years and older, English speaking, independent living. 
If you are interested and agree to participate you 
would be asked to: have your muscle mass measured 
using an ultrasound machine, have your muscle 
strength tested, measure your height and weight, and 
record a 3 day food record.    
Your participation would involve 1-2 sessions.  
The first session will be approximately 15 mins where 
we will explain the study and ask you to consent; the 
second session will be approximately 1 hour long 
where we will conduct all measurements, including 
the explanation of the food record.   
For more information about this study, or to volunteer for this study, 
please contact: 
Dr. Janet Madill, Principal Investigator  
Brescia University College, Western University 
519 432 8353 Ext 28240 or 
Email: jmadill7@uwo.ca 
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SECTION: 
SUBJECT: 
APPROVED BY: 
Purpose: 
Policies and Programs INDEX: FS-M7 
Menu-Canada's Food Guide & Portions PAGE: I of2 
Sr. V.P. of Human Resources 
CANADA'S FOOD GUIDE l 
The menu is based on Canada's Food Guide and portions for the elderly resident are 
suggested for optimal resident nutrition & satisfaction. 
Procedure: 
• Suggested number of servings and portion sizes will be available to all residents as
per the following table .
Product Product # Servings Small Regular Large 
Per day Portion Portion Portion 
Milk 3 oz/ 4 oz/125 ml 6 oz/175 ml 
Milk Yoaurt 3 oz 6 oz/175 ml 8 oz/250 ml 
Cottaae cheese 3oz 4 oz/125 ml 6 oz/175 ml 
Milk Products Ice Cream 2 3 oz 4 oz/125 ml 6 oz/175 ml 
Milk Puddina 3 oz 4 oz/125 ml 6 oz/175 ml 
Cream Soup 3 oz 4 oz/125 ml 6 oz/175 ml 
Bread, white ½slice . 1 slice 2 slices 
Cereal, cooked 3oz 4 oz/125 ml 6 oz/175 ml 
Cereal, cold ½ 1 oz/30 ml 2 oz/60 ml 
Muffin ½ 1 1 
Biscuit, tea ½ 1 1 
Roll, dinner ½ 1 1 
Roll, ham/hotdoa ½ 1 1 
Grains Pizza crust 5 1/10of10" 1/8 of 10" 1/6of10" 
Baael or pita 1/3 ½ regular 1 whole 
Cake, white 1x1" 1.5x1 .5" 2x2" 
Cookie, suaar 1 2 3 
Cracker, soda 4-6 6-8 8-10
Pasta 3 oz 4 oz/125 ml 6 oz/175 ml
Rice 3 oz 4 oz/125 ml 6 oz.175 ml
Meat, Fish, poultry 1 oz/25 g 2 oz/50 g 4 oz/100g
boneless 
Meat Chicken, bone in 2 oz/50 g 3.5 oz/100 g 4 oz/100 g 
& Enn 2 1 small 1 medium 1 large 
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Alternates Lequmes ,, 
Peanut butter 
Nuts 
Sliced meat 
Potato 
Anv vea, cooked 
Vegetables Fruit, fresh/whole 
& Fruit iuices 
Fruit Raisins 5 
Salad, leaf greens 
Salad, grated 
Prunes/Fruit Lax 
Beef Stew 
Combination Macaroni & Cheese 
Foods Tuna Noodle Casser< 
Baked Beans 
Fresh Fruit 
Snacks Cheese & Crackers 
Sandwich 
2 oz 
1T/15ml 
1/8 c/25 ml 
1 oz 
2 oz 
2 oz 
½ medium 
2 oz 
1 T/15 ml 
½ c/125 ml 
¼c 
2 whole/2 oz 
4 oz/125 ml 
4 oz/125 ml 
2 T/30 ml 
¼c/50 ml 
2 oz 
4 oz/125 ml 
4 oz/125 ml 
1 medium 
4 oz/125 ml 
2T/30 ml 
1 c/250 ml 
½c/125ml 
3 whole/3 oz 
6 oz/175 ml 
1 small 
6 oz/175 ml 
3 T/45 ml 
1/3 C 
4 oz 
6 oz/175 ml 
6 oz/175 ml 
1 large 
6 oz 
3 T/45 ml 
1.5c 
1 c/250 ml 
4whole/4 o 
8 oz/250 ml 
1 oz/2 crackers 
½ 
Conversions & Equivalents (Measurements for Portion Sizing) 
Scoop Sizes #8 
#12 
#16 
#20 
#24 
#30 
Weights 1 oz 
1 pound 
2.2 pounds 
Measures 3t 
2T 
16 T 
Imperial Measures 1 cup 
2.5 cups 
5 cups 
4 auarts 
4 oz 
2-3/8 oz
2 oz
1-5/8 oz
1-1/3 oz
1 oz
approx. 30g 
16 oz 
1 kq 
1 T 
1 fl.oz. 
1 CUP
250ml 
1 pint 
1 quart 
1 gallon 
125 ml 
70ml 
60ml 
50ml 
40ml 
30ml 
454 g 
15 ml 
8 oz/250 ml 
20 oz/600 ml 
40 oz/1200 ml 
160 oz/4800 ml 
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Medical Directive Title: 
Use of Bedside Ultrasound to Assess Lean Muscle Mass as a 
Component of Nutrition-Focused Physical Assessment for Low-Risk 
Institutionalized Elderly Participants in McGarrell Place Long-Term 
Care Home 
Lead Contact Person: 
Dr. Janet Madill, PhD, RD 
Assistant Professor at Brescia University College, Research Chair for 
Nutrition and Transplantation, 
Brescia University College, Rm MSJ 181 
Tel: 519-432-8353 Ext. 28240 
Email: jmadill7@uwo.ca 
Physician Lead: 
Dr. Karen Ka-Wing Lo, MD, Primary Physician of the McGarrell Place 
Long-Term Care Home, 
McGarrell Place Long-Term Care Home, 
Tel: 519-672-0500 
Email: mcgarrell@reveraliving.com 
Program: Long-Term Care 
Approval By: Medical Advisory Committee 
Original Effective Date: Revised Date: To Be Reviewed Date: 
This Medical Directive Applies to the following participant population: 
 In-Patients      Out-Patients  Adults   Paediatrics   Neonates 
Order: 
• Identify the Order(s)/Treatment(s)/Intervention(s) Specifically.  If there are multiple medications, laboratory tests
or treatments please use appendix “F” to identify details and use this space for an overview / rational of this
directive.
• This directive allows for the delegation of applying a prescribed form of energy, in the form of high frequency
ultrasonic waves, to a Registered Dietitian (RD) and/or dietetic graduate student for the purposes of measuring
Lean Muscle Mass (LMM) using a portable ultrasound (US) machine. It is within the scope of practice for RDs
and dietetic graduate students with specialized training in utilizing US to capture and quantify LMM of the
quadriceps muscle layer thickness (QMLT) for the purpose of conducting: 1) a comprehensive nutrition-focused
physical assessment and/or 2) research related to the loss of LMM and loss of muscle strength, coined
“sarcopenia”, which has been associated with numerous poor outcomes in the geriatric population including:
disabilities, frailty, falls, fractures, poor quality of life and mortality in the recent literature (1)(2)(3)(4).
Appendix Attached?  Yes   No 
Please ensure you include appendix with your Medical Directive submission 
Recipient Participants: 
• In broad terms identify which residents may receive the order including the clinical and situational conditions
required
• This medical directive will apply to low-risk, institutionalized, elderly participants in McGarrell Place Long-Term
Care Home provided that these residents meet the study inclusion criteria and have given their written consent
to participate in the study. (REB #107739)
Authorized Implementers: 
• Identify individuals or groups of individuals by position and qualifications who will be involved in implementing
the medical directive
Catalogue # (for use by Medical Affairs) 
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Position / Title Qualifications / Certifications 
Janet Madill, Assistant Professor at Brescia 
University College, Research Chair for 
Nutrition and Transplantation 
PhD, RD 
Catherine Brown, RD, Research Assistant RD 
Nesrine Cheikh RD, DDEPT, MScFN (c) 
Amanda Dufault MScFN (c) 
 
Indications & Contraindications: 
• Indications: Identify specifically when and under what conditions the directive applies.
• Contraindications: Identify conditions that would preclude implementation of the order or delegation. Identify
what actions should be taken.
Indications: 
• The initial approach will be conducted by Lynn Mellows the registered dietitian in the McGarrell Place Long-Term
Care Home who will introduce the study to the participant. The introduction to the study team will then be made
by the dietitian, and the study team will determine suitability of participants based on the inclusion/exclusion
criteria
• Inclusion Criteria:
§ ≥ 65 years old
§ English speaking and able to provide consent
§ Ambulatory
Contraindications 
• Refusal of participant consent for testing
• Exclusion Criteria:
§ < 65 years of age
§ Non-English speaking or not able to provide consent
§ Non-ambulatory
§ Moderate to severe dementia
• Actions if contraindicated: No further follow up by study team, resident will continue to receive standard of care.
Medication / Drug Table:  
Please identify all medications/drugs, using the chart below, which are included under this medical directive by listing 
the AHFS classification and then identifying which drugs are INCLUDED and specific to your practice.   
Note: medical directives for medication orders excludes: non-formulary medications, special access 
program medications/investigational drugs, off-label use medications, and narcotics, controlled drugs, and 
benzodiazepines (definition of practitioner as defined under CDSA and Narcotic Regs restricts prescribers). 
For any off-label use of a specific medication to be included, the actual drug and indication must be listed 
individually and not in the AHFS classification section (e.g. Gabapentin for pain).  
Drug Name (GENERIC) 
LIST INCLUSIONS  
Indications Route of Administration Special Consideration 
(e.g. monitoring, lab 
tests) 
None 
Consent 
• Identify who will obtain consent and when.
• Once inclusion is established, the study team and/or Lynn Mellows and Pat Jones from the McGarrell Place
Long-Term Care Home will provide the participant with the Letter of Information (LOI) and Consent Form.
Educational Requirements 
• Identify any additional information or educational requirements to guide practice (e.g. Educational package)
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• Identify any ongoing competencies needed
• Current Registration with the College of Dietitians of Ontario
• Guided training with PI and Sonosite Clinical Specialist, with expertise using an ultrasound image of the
quadriceps to obtain a measurement for the QMLT using the FUJIFILM SonoSite MTurbo portable US machine
• Demonstrated understanding of rationale for using US to capture and measure the QMLT
• Demonstrated skill in locating the top of the patella and anterior superior iliac spine (ASIS)
• Demonstrated ability to measure and mark the upper two-thirds between the ASIS and the upper pole of the
patella, as well as the midpoint between the ASIS and the upper pole of the patella
• Demonstrated ability to apply transmission gel and press the transducer against the skin surface at a 90o angle
(perpendicular to the skin), with minimal compression, once the appropriate area is visualized on screen
• Demonstrated ability to identify the anatomical landmarks as viewed on the ultrasound monitor/screen
• Ability to correctly position calipers to obtain an accurate measurement of the QMLT
• Demonstrated knowledge of infection control processes
• Identification of and appropriate management of adverse/allergic reactions
• Ongoing competencies maintained through performance of a minimum of five procedures per year
(See Appendix B)
Appendix attached?  Yes   No 
Please ensure you include appendix with your Medical Directive submission 
Documentation & Communication 
• Identify all standard documentation requirements for the order(s) or procedure(s) (i.e. documentation standards
for the participant health record).
• The dietitian will document remarkable findings/impressions/recommendations in the participant’s health record,
according to established college guidelines, and in the study chart.
Review and Quality Monitoring Guideline: 
• Identify how issues will be addressed using this directive (e.g. How to address questions or clarification
requirements, new information, unanticipated outcomes)
• Identify who to contact and how to proceed.
• Review and monitoring will be completed in accordance with McGarrell Place Long-Term Care Home Medical
Directive policy
• Concerns regarding administration or results of the medical directive can be discussed with the attending
physician and/or RD
Professional Staff Approvals (Physician, Dentist, Midwife): 
• Identify all Professional Staff members (less than 10 list by individual name, greater than 10 list
by title & program) responsible for participants who may receive an order or procedure under
this medical directive.
NAME DEPARTMENT / PROGRAM 
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Administrative Authorization Approval Form 
Please note:  signature pages are not to be signed until the medical directive has been approved. 
Name of Directive: Use of Bedside Ultrasound to Assess Lean Muscle Mass as a Component  
of Nutrition-Focused Physical Assessment for Low-Risk, Institutionalized Elderly Participants in 
McGarrell Place Long-Term Care Home 
Lead Contact Person (s): Dr. Janet Madill, PhD, RD, Assistant Professor at Brescia University 
College, Research Chair for Nutrition and Transplantation, Brescia University College, Rm MSJ 
181, Tel: 519-432-8353 Ext. 28240, Email: jmadill7@uwo.ca 
IMPORTANT: This template is a general document that may need modification based on the needs 
of the directive. Please modify appropriately. 
• Identify all administrative bodies, including individuals (PPL’s, managers, directors, chiefs) and other
approving bodies (i.e. Medical Advisory Committee, Drug & Therapeutics Committee) that must
approve the medical directive.
Administrative Authorizations 
(approved by): 
Signature Date 
Implemented by: 
(Person(s) performing initiation or 
person representing a large group and 
responsible for notification of that 
group) 
Signature Date 
Janet Madill, PhD, RD, Assistant 
Professor at Brescia University College, 
Research Chair for Nutrition & 
Transplantation 
Catherine Brown, BSc, RD, Research 
Assistant 
Nesrine Cheikh, RD, DDEPT, MScFN (c) 
Amanda Dufault, MScFN (c) 
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Name of Directive: Use of Bedside Ultrasound to Assess Lean Muscle Mass as a Component  
of Nutrition-Focused Physical Assessment for Low-Risk, Institutionalized Elderly Participants in 
McGarrell Place Long-Term Care Home 
Lead Contact Person (s): Dr. Janet Madill, PhD, RD, Assistant Professor at Brescia University 
College, Research Chair for Nutrition and Transplantation, Brescia University College, Rm MSJ 
181, Tel: 519-432-8353 Ext. 28240, Email: jmadill7@uwo.ca 
IMPORTANT: This template is a general document that may need modification based on the needs 
of the directive. Please modify appropriately. 
Order Indications Contraindications Notes (optional) 
Purpose of Medical Directive: 
According to the Jurisprudence Handbook for Dietitians in Ontario, registered dietitians have to 
abide by a set of controlled acts. These controlled acts are described as “health care actions that are 
considered potentially harmful if performed by unqualified persons”. There are currently 13 acts that 
“should only be performed by someone with the legal authority to do so”. Dietitians engaging in ultrasound 
imaging require a medical directive due to controlled act 7 which states that “applying or ordering the 
application of a form of energy prescribed by the regulations under this Act”. This controlled act 
specifically reads that when: 
“Applying a prescribed form of energy, [referring] to electricity, electromagnetic energy, or sound 
waves. Electrical impedance testing, while electrical in nature, is not prohibited in the regulations made by 
the Minster of Health and Long-Term Care. Moreover, this controlled act does not apply to the energy 
level of diets, enteral nutrition or TPN. Food energy is also not part of this controlled act.” (5) 
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Volunteer	Food	Intake	Guide	1. Room	number	will	be	located	on	each	food	intake	record	sheet	at	the	top	leftcorner	to	assist	you	in	recording	food	and	beverage	intake	in	the	resident’s	room.2. Diet	order	will	be	located	on	each	food	intake	record	at	the	top	left	corner	andwill	also	be	highlighted	in	yellow	which	will	assist	you	to	know	which	meal	plan	toreview	on	the	menu	sheets.3. Diet	modifications	such	as	“small	portions”,	“added	sauce”,	“added	flax”,“resource	2.0	after	meal”,	etc	will	be	located	on	each	food	intake	record.4. Observe	residents	consistently	throughout	meal-time	for	added	salt,	refillsdouble	portions.*ALL	COFFEE	IS	DECAF5. Observe	RED	cups:	This	means	there	may	be	a	medication	mixed	in	with	a	fluid(such	as	a	laxative)	or	this	cup	may	contain	a	supplement	such	as	Resource	2.0.Communicate	with	nurse	providing	this	to	the	resident.6. Observe	how	fast/slow	they	consume	their	meal	and	make	note	of	this	on	thefood	intake	record	in	order	for	other	volunteers	who	are	observing	the	resident	toensure	they	are	recording	accurately	and	in	a	timely	manner	before	the	food	isremoved	from	their	table.7. Observe	the	amount	that	is	being	served	and	record	this	in	“amount”	section	onthe	food	record	(ex:	125	ml	cup	or	1	8scoop).	Then,	observe	amount	consumed	bythe	resident	and	record	this	in	“notes”	section	of	the	food	intake	record	(ex:	ifresident	has	consumed	half	of	one	of	the	meal	components,	write	down	“finished	orate	half”	instead	of	“left	half”).8. There	are	different	sizes	for	different	glassware	that	are	not	always	depictedaccurately	in	the	McGarrell	menu.	Here	is	a	summary	to	assist	you	in	yourrecording:- Small,	clear	water	/	juice	glass	=	125mL- White	porcelain	coffee	mug	=	150mL- Yellow	/	beige	insulated	coffee	mug	=	180mL- Grey	/	beige	coffee	mug	=	200mL- Teal	coffee	mug	=	250mL- Wider,	clear	water	/	juice	glass	=	250mL9. Observe	sample	plates	located	at	the	serving	station	for	portion	sizes	and/orsubstitute	meal	components	that	may	not	be	on	the	menu.
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10. Always	ask	if	the	resident	is	finished	consuming	their	meal	before	making	anyfinal	recordings.11.Write	down	the	date	of	recording	on	each	food	intake	record.12.Write	down	your	initials	and	create	a	line	where	you	have	stopped	recordingthe	resident’s	food	intake	on	the	food	intake	record.13. Occasionally	check	the	resident’s	room	at	snack	times	or	in	between	snacks	anddinner	to	see	if	snacks/beverages	may	have	been	consumed	between	meals.	Youmay	do	this	approx	3	times	in	the	day:	between	am	snack	and	lunch,	hs	snack	anddinner,	and	dinner	and	pm	snack14. If	you	find	a	resident	is	missing	during	a	meal:a) If	resident	has	had	meal	from	outside	the	institution	or	with	a	POA,	touch	base
with	the	resident/POA	to	ask	what	they	have	consumed	during	their	time	out.b) If	resident	felt	ill	during	this	meal	time,	touch	base	with	the	resident	or	nursingstaff	when	possible	to	identify	cause	of	missing	meal.c) If	resident	is	asleep:	touch	base	with	resident	when	they	are	awake	to	see	if	theyplan	on	having	a	late	meal.15. Ensure	ALL	documents	are	placed	in	their	proper	folders	which	are	labeled	andplaced	in	the	third	drawer	near	the	sink	in	the	Wellness	Center	Room	in	“Kingsmill”unitIf	you	have	any	questions,	please	contact	Nesrine	Cheikh	313-338-7233	or	Karen	
Sevong	647-527-2368.	
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Telephone Script: Research Team 
Contacting participants for collecting food record 
Hello, may I please speak with {insert the name of the participant here}. 
*If the potential participant is not home ask if there is a better time to call. Do not leave a
message as it may be a confidential matter you are calling about that may not be
apparent to you*
*If they are home, continue with the conversation*
Hi {insert the name of the participant here}, this is {insert your name here} and I am
working with Dr. Janet Madill in the study you recently consented to be a part of looking
at measuring your muscle mass and your food intake. I understand you agreed to be
contacted in order to review your 3-day food record with us.
Would this be a good time for us to review your food intake from today? 
*If the participant states this is not a convenient time, ask if there is a better time to call.*
*If the participant declines to have a food record collected, thank them for their time and
say good-bye*
*If you have received permission from the participant, please continue to fill in what they
have eaten*
[Starting with]: What is the first thing you have had to eat or drink today? 
[End with]: Do you have any further questions at this time? 
{Answer any questions they may have} 
*In the event that a participant asks you for any type of nutrition counseling or advice
please read the following statement as we are not qualified to provide these services
and therefore doing so would be unethical*
Unfortunately for the purpose of this study, I am not qualified to provide nutrition 
consultation at this time. If you wish to review your nutrition information after the study 
has been complete, my principal investigator, Dr. Janet Madill, would be happy to do 
that with you. If you have any further questions related to this issue, you may contact 
her directly at the following phone number 519-432-8353 Ext. 28240. 
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MCTM
Subjective Global Assessment Form
DIETARY INTAKE
WEIGHT Usual weight Current weight 
SYMPTOMS (Experiencing symptoms affecting oral intake)
METABOLIC REQUIREMENT
CACHEXIA
PHYSICAL EXAMINATION
SGA RATING
FUNCTIONAL CAPACITY (Fatigue and progressive loss of function)
1. No change; adequate
2. Inadequate; duration of inadequate intake
 Suboptimal solid diet  Full fluids or only oral nutrition supplements  Minimal intake, clear fluids or starvation
3. Dietary Intake in past 2 weeks*
Adequate  Improved but not adequate  No improvement or inadequate 
1. No dysfunction
2. Reduced capacity; duration of change
Difficulty with ambulation/normal activities  Bed/chair-ridden
3. Functional Capacity in the past 2 weeks*
 Improved  No change  Decrease 
 A Well-nourished  B Mildly/moderately malnourished  C Severely malnourished 
Normal Some progressive nutritional loss Evidence of wasting and progressive symptoms
Loss of body fat  No  Mild/Moderate  Severe
Loss of muscle mass  No  Mild/Moderate  Severe
Presence of edema/ascites   No  Mild/Moderate  Severe
High metabolic requirement   No  Yes
 No  Yes
1. Non fluid weight change past 6 months Weight loss (kg) 
 <5% loss or weight stability   5-10% loss without stabilization or increase >10% loss and ongoing
If above not known, has there been a subjective loss of weight during the past six months?
 None or mild  Moderate  Severe
2. Weight change past 2 weeks* Amount (if known)
 Increased  No change  Decreased
1. Pain on eating  Anorexia  Vomiting  Nausea  Dysphagia  Diarrhea
Dental problems  Feels full quickly  Constipation
2. None  Intermittent/mild/few  Constant/severe/multiple
3. Symptoms in the past 2 weeks*
 Resolution of symptoms  Improving  No change or worsened
*See page 2 SGA Rating for more description.
MEDICAL HISTORY
Patient name: Date:  /  /
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MCTM
Subjective Global Assessment Guidance For Body Composition
SUBCUTANEOUS FAT
Physical examination Normal Mild/Moderate Severe
Under the eyes Slightly bulging area Somewhat hollow look, Slightly 
dark circles, 
Hollowed look, depression, dark 
circles
Triceps Large space between fingers Some depth to fat tissue, but not 
ample. Loose fitting skin.
Very little space between fingers, 
or fingers touch 
Ribs, lower back, sides of trunk Chest is full; ribs do not show. 
Slight to no protrusion of the iliac 
crest
Ribs obvious, but indentations are 
not marked. Iliac Crest somewhat 
prominent
Indentation between ribs very 
obvious. Iliac crest very prominent
MUSCLE WASTING
Physical examination Normal Mild/Moderate Severe
Temple Well-defined muscle Slight depression Hollowing, depression
Clavicle Not visible in males; may be 
visible but not prominent in 
females
Some protrusion; may not be all 
the way along
Protruding/prominent bone
Shoulder Rounded No square look; acromion 
process may protrude slightly
Square look; bones prominent
Scapula/ribs Bones not prominent; no 
significant depressions
Mild depressions or bone may 
show slightly; not all areas
Bones prominent; significant 
depressions
Quadriceps Well defined Depression/atrophy medially Prominent knee, Severe 
depression medially
Interosseous muscle between 
thumb and forefinger (back of 
hand)**
Muscle protrudes; could be flat in 
females
Slightly depressed Flat or depressed area
FLUID RETENTION
Physical examination Normal Mild/Moderate Severe
Edema None Pitting edema of extremities / 
pitting to knees, possible sacral 
edema if bedridden
Pitting beyond knees, sacral 
edema if bedridden, may also 
have generalized edema
Ascites Absent Present (may only be present on imaging)
Prior to giving the final rating, the evaluator must determine whether changes in body composition and body weight are due to decreased food 
intake or to cachexia/disuse. If there is evidence of reduced muscle and fat and no improvement with optimal nutrient intake, this is consistent 
with cachexia. If cachexia is present, SGA rating may be SGA A despite body composition changes of weight loss, muscle wasting and 
subcutaneous fat loss.
A - Well-nourished no decrease in food intake; < 5% weight loss; no/minimal symptoms affecting food intake; no deficit in function; no deficit 
in fat or muscle mass OR *an individual with criteria for SGA B or C but with recent adequate food intake; non-fluid weight gain; significant 
recent improvement in symptoms allowing adequate oral intake; significant recent improvement in function; and chronic deficit in fat and 
muscle mass but with recent clinical improvement.
B - Mildly/moderately malnourished definite decrease in food intake; 5% - 10% weight loss without stabilization or gain; mild/some 
symptoms affecting food intake; moderate functional deficit or recent deterioration; mild/moderate loss of fat and/or muscle mass OR *an 
individual meeting criteria for SGA C but with improvement (but not adequate) of oral intake, recent stabilization of weight, decrease in 
symptoms affecting oral intake, and stabilization of functional status.
C - Severely malnourished severe deficit in food intake; > 10% weight loss which is ongoing; significant symptoms affecting food intake; 
severe functional deficit OR *recent significant deterioration obvious signs of fat and/or muscle loss.
**In the elderly prominent tendons and hollowing is the 
result of aging and may not reflect malnutrition.
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Ultrasound Output 
Left QMLT Right QMLT 
ACIS to Patella 
Measurement 
ACIS to Patella 
Measurement 
Measurement 1 Measurement 1 
Measurement 2 Measurement 2 
Average 
Measurement 
Average 
Measurement 
Handgrip Strength 
Left Hand Right Hand 
Measurement 1 Measurement 1 
Measurement 2 Measurement 2 
Measurement 3 Measurement 3 
Average 
Measurement 
Average 
Measurement 
Average 
Left Hand Right Hand 
Reference Average for Age and 
Gender 
Subjective Global Assessment 
Score 
           A  B  C 
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Participant Study #: ___________ Study Group: __________________ Date: ______________ 
Appendix L
Participant Study #: ___________ Study Group: __________________ Date: ______________ 
Bioelectrical Impedance Analysis (BIA) Output 
Measure Value 
Height (cm) 
Weight (kg) 
Age 
Gender 
Body Fat 
% 
kg 
Lean body mass (kg) 
Total (kg) 
Dry 
Body Water 
% 
L 
ICW 
ECW 
BMR 
kcal/kg 
BMI 
BFMI 
FFMI 
Reactance 
Resistance 
Wellness Marker 
Phase Angle 
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Food Intake Analysis 
Total Calorie Intake Total Protein Intake 
24 – Hour Recall 
Day 1 
Day 2 
Day 3 
Average 
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Resident Medical History Form 
Name: ___________________ 
Room Number: ___________ 
Code Number: ___________ 
Age: ___________ 
Height: __________ 
Weight: ___________  Date: ______________ 
Admit Weight: ____________    Date: __________________ 
Medications:
  Vitamin D 1000 IU 
    Vitamin B12 Injection 
      Vitamin B12 Tablets  
Other Medications: 
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Focus	groups	
Differences	in	quadriceps	muscle	layer	thickness	(QMLT)	size	and	contributing	risk	
factors	in	free-living	and	low-risk	institutionalized	older	adults:	A	cross-sectional	
mixed-methods	study	
WELCOME	&	INTRODUCTION	 (2	min)	Hello	everyone.	My	name	is	_______.	I	would	like	to	welcome	you	and	thank	you	for	participating	in	our	focus	group	here	today.	I	am	going	to	be	your	Moderator	for	the	session	and	_______	will	be	our	Assistant	Moderator.		For	those	of	you	who	are	unfamiliar	with	what	a	focus	group	is,	a	focus	group	consists	of	a	small	group	of	participants	that	are	led	through	an	open	discussion	by	a	moderator.	Today’s	discussion	will	take	approximately	50	minutes.	There	are	no	right	or	wrong	answers.	We	would	just	like	to	hear	your	thoughts	and	opinions	about	the	questions	we	ask	you	here	today.			The	purpose	of	today’s	discussion	is	to	explore	your	eating	patterns	in	order	to	obtain	a	better	contextual	understanding	of	your	dietary	intake	beyond	your	food	intake	records	we	previously	(or	are	currently)	conducted	(conducting)	with	you.	Specifically,	this	will	assist	us	in	identifying	eating	habits	that	may	affect	your	intake.	The	Assistant	Moderator	will	not	be	participating	in	the	discussion.	She/he	will	be	taking	notes	for	data	analysis.	We	will	also	have	two	tape	recorders	recording	our	session	today.	The	audio	recordings	will	allow	the	research	team	to	accurately	transcribe	what	we	as	a	group	discussed	here	today	in	order	for	the	information	to	be	properly	analyzed	and	summarized.		Your	privacy	is	important	to	us.	We	ask	that	all	comments	made	during	this	discussion	be	kept	confidential.	All	comments	will	remain	anonymous	and	your	name	or	any	other	personal	information	will	not	be	used	in	any	publications.	In	addition	to	respecting	privacy	and	confidentiality,	we	have	also	listed	some	ground	rules	for	our	discussion.	We	invite	each	of	you	to	(a)	participate	actively	in	the	discussion;	(b)	respect	each	other;	(c)	provide	feedback	with	an	open	mind;	and	(d)	respect	confidentiality.	Would	anyone	like	to	add	anything	before	we	start?	
QUESTIONS	(~10	minutes	each)	1. HOW	WOULD	YOU	DESCRIBE	YOUR	EATING	PATTERNS
Probe:	How	many	times	do	eat?		When	do	you	eat?	Do	you	eat	at	home?	Doyou	eat	out?	How	often	do	you	cook	meals	at	home?	Do	you	eat	in	a	socialsetting	or	alone?	Do	you	find	you	eating	patterns	are	fairly	consistent	orchange	day	by	day?2. DO	YOU	THINK	YOU	EAT	WELL?	WHY	OR	WHY	NOT?
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Probe:	What	does	eating	well	look	like	to	you?	Why	do	you	think	you	might	eat	this	way?	What	is	one	eating	behavior	that	you	consider	to	be	doing	well?	What	is	one	that	you	could	improve	on?	3. IS	THERE	ANYTHING	THAT	WOULD	SUPPORT	YOU	TO	EAT	BETTER?
Probe:	What	are	supports	you	currently	have	to	assist	in	your	eating	habits?How	could	these	current	support	be	expanded	to	further	assist	you?	Do	youhave	access	to	cooking	facilities?	Do	you	enjoy	the	food	you	eat?	Are	there	anybarriers	that	stop	you	from	eating?4. HOW	WOULD	YOU	DESCRIBE	THE	BIGGEST	CHALLENGES	TO	EATINGPROTEIN
Probe:	What	foods	do	you	identify	with	as	being	rich	in	protein?	What	kindsof	protein-rich	foods	do	you	eat?	Do	you	have	any	dietary	restrictions	withprotein?	Do	you	have	access	to	protein	rich	foods?5. ANYTHING	ELSE	YOU	WOULD	LIKE	TO	ADD?
CLOSING	Thank	you	very	much	for	attending	our	focus	group	session.	We	really	appreciate	your	time	and	effort	in	attending	these	focus	groups.	We	will	be	using	the	information	gathered	here	today	to	identify	some	major	themes	in	the	eating	habits	of	__________________________	(free-living	or	institutionalized	elderly)	and	relating	this	information	back	to	the	data	obtain	from	your	food	intake	records.	All	of	this	information	will	be	used	to	further	advance	nutrition	related	information	available	in	regards	to	sarcopenia	prevention	and	treatment.	We	hope	to	be	able	to	share	our	results	with	everyone	when	the	study	is	complete.		
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         MALE   FEMALE 
Age  Low % High % Low % High % 
  1  -  4 16 20 15 19 
  5  -  9 12 15 15 19 
  10  -  19 12 18 18 25 
  20  -  30 12 18 20 26 
  31  -  40 13 19 21 27 
  41  -  50 14 20 22 28 
  51  -  60 16 20 22 30 
> 61 17 21 22 31 
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constitute a waiver of either party's right to enforce each and every term and condition
of this Agreement. No breach under this agreement shall be deemed waived or
excused by either party unless such waiver or consent is in writing signed by the party
granting such waiver or consent. The waiver by or consent of a party to a breach of
any provision of this Agreement shall not operate or be construed as a waiver of or
consent to any other or subsequent breach by such other party.
This Agreement may not be assigned (including by operation of law or otherwise) by
you without WILEY's prior written consent.
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Any fee required for this permission shall be non-refundable after thirty (30) days
from receipt by the CCC.
These terms and conditions together with CCC's Billing and Payment terms and
conditions (which are incorporated herein) form the entire agreement between you and
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes
all prior agreements and representations of the parties, oral or written. This Agreement
may not be amended except in writing signed by both parties. This Agreement shall be
binding upon and inure to the beneﬁt of the parties' successors, legal representatives,
and authorized assigns.
In the event of any conﬂict between your obligations established by these terms and
conditions and those established by CCC's Billing and Payment terms and conditions,
these terms and conditions shall prevail.
WILEY expressly reserves all rights not speciﬁcally granted in the combination of (i)
the license details provided by you and accepted in the course of this licensing
transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment terms
and conditions.
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor
Type was misrepresented during the licensing process.
This Agreement shall be governed by and construed in accordance with the laws of
the State of New York, USA, without regards to such state's conﬂict of law rules. Any
legal action, suit or proceeding arising out of or relating to these Terms and Conditions
or the breach thereof shall be instituted in a court of competent jurisdiction in New
York County in the State of New York in the United States of America and each party
hereby consents and submits to the personal jurisdiction of such court, waives any
objection to venue in such court and consents to service of process by registered or
certiﬁed mail, return receipt requested, at the last known address of such party.
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription
journals offering Online Open. Although most of the fully Open Access journals publish
open access articles under the terms of the Creative Commons Attribution (CC BY) License
only, the subscription journals and a few of the Open Access Journals offer a choice of
Creative Commons Licenses. The license type is clearly identiﬁed on the article.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and
transmit an article, adapt the article and make commercial use of the article. The CC-BY
license permits commercial and non-
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC)License permits use,
distribution and reproduction in any medium, provided the original work is properly cited
and is not used for commercial purposes.(see below)
Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND)
permits use, distribution and reproduction in any medium, provided the original work is
properly cited, is not used for commercial purposes and no modiﬁcations or adaptations are
made. (see below)
Use by commercial "for-proﬁt" organizations
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Use of Wiley Open Access articles for commercial, promotional, or marketing purposes
requires further explicit permission from Wiley and will be subject to a fee.
Further details can be found on Wiley Online Library
http://olabout.wiley.com/WileyCDA/Section/id-410895.html
Other Terms and Conditions:
v1.10 Last updated September 2015
Questions? customercare@copyright.com or +1­855­239­3415 (toll free in the US) or
+1­978­646­2777.
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The University of Western Ontario 
London, Ontario, Canada 
2010-2014 BScFN 
The University of Western Ontario 
London, Ontario, Canada 
2014-2015 Dietetic Internship/DDePT
•Current registration with the College of Dietitians
of Ontario: #14194 June 2015
•Brescia Faculty award, 2013
•Dr. Patricia M. Giovannetti Graduate Studies
Award 2015 Scholarship
•Registered Dietitian: Nutrition Professionals of Canada - June 2018-Present
•Registered Dietitian: Springbank Medical Center: February 2018-Present
•Registered Dietitian at DoctorCare Inc: 2016-2018
•Brescia University College Course Assistant: 2015-2016
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